Pages
Posts
Addiction
- The Science of Addiction and The Brain
- The Neuroscience of Addiction
- Substance Abuse ‘Under-appreciated’ Among Elderly Psychiatric Inpatients
- Panel Votes Against Hydrocodone Because Of Abuse Potential
- Neuroscience – Addiction and the Brain
- Marijuana Use Linked To Better Adherence In Psychosis
- Combination Therapy Yields Mixed Results for PTSD, Substance Abuse
- Addiction Neuroscience 101
ADHD
- What is ADHD?
- Understanding the scattered (ADHD) brain
- Titrate ADHD Meds Quickly for Best Outcome
- Liquid, Extended-Release Drug Approved For ADHD
- Is ADHD An Advantage?
- Genetic Discoveries May Help Kids With ADHD, Expert Says
- Current Digital Applications in Psychiatry, Specifically ADHD
- ADHD in Adulthood: The Signs You Need to Know
All Articles For Neurology
- Why some multiple sclerosis- patients stop disease modifying treatment in MS and why some don’t start at all
- What’s New In Parkinson’s Rating Scales?
- Welcome Message From The Co-Chairs Of The International Scientific And Organising Committee
- Weight Lifting Improves Physical Function in Parkinson’s
- Weighing Botox’s Migraine Benefits Against Costs
- WCNR2022: Experts discuss new findings on how to help the nervous system in the reorganisation process after irreversible damage
- Voice Disturbance Analysis Detects Parkinson’s
- Vitamin D Levels Correspond to Disability in MS
- Visual stress: origins and treatment
- Uncontrolled Hypertension Could Bring Increased Risk For Alzheimer’s Disease
- Treatment Options For Atypical Parkin-Sonisms
- Treating Brain Tumors With Bacteria Gets Neuro-surgeons Banned
- Trauma-Induced Epilepsy May Be Prevented By Cooling The Brain Following Injury
- Transcranial Neuro-stimulation Reduced Postop Pain, Opioid Use
- Topical Pain Relievers: FDA Issues Burn Warning
- Time To First Relapse As An Endpoint In Multiple Sclerosis Clinical Trials
- The Role Of Apomorphine In The Effective Management Of Parkinson’S Disease – Highlights From Cony 2014
- The Clinical Validation Of Objective Measurement Of Movement In Parkinson’s Disease
- The Angels (Acute-Networks StrivinG For ExceLlence In Stroke) Initiative: Solving A Problem By Giving Physicians The Tools They Need To Create A Solution
- THC Fails to Delay Progression of Multiple Sclerosis
- Tenecteplase Edges TPA in Acute Stroke
- Technical Advances In Neurosurgery
- Tai Chi Improved Postural Stability in Parkinson’s Disease
- Symptom Triad May Identify Parkinson’s Risk
- Surgical Removal of Brain Thrombus Boosts Recovery
- Study Suggests New Potential Alzheimer’s Treatment Strategy
- Study Hints at Statins’ Protective Effect Against Parkinson’s
- Study Finds Many Missed MS Diagnoses in Emergency Department
- Study Finds Long-Term Benefits Of DBS In Refractory Epilepsy
- Studies Identify Early Changes In Familial Alzheimer’s Disease
- Strokes Mix Up Brain And Muscle Coordination
- Stroke Treatment From Onset To Rehabilitation
- Stroke Severity Is Key in Hospital Rankings for Stroke Outcomes
- Stroke Prevention in AF: Study Finds Some Differences Among New OACs
- Stroke care taking flight with the wings of ANGELS
- Stroke Association Reviewing Stroke Definition, New Anticoagulants
- Spinal Cord Stimulation an Option for Chronic Pain
- Some Recommendations To Address The Burden Of Stroke In Europe
- Solitaire Trumped Merci in Stroke Clot Retrieval Trial
- Solitaire Clot Remover Effective for Large Artery Stroke
- Skin Cancer Drug Steps Into New Alzheimer’s Study
- Significant Risk Factors In The Etiology Of Arterial Ischemic Stroke In Children
- Selecting patients for endovascular therapy and recent developments and clinical experience with Medtronic devices
- Secondary Headaches Flag Medical Conditions in Pregnancy
- Scores Help Identify Stroke Patients at Risk of Brain Bleed
- Rotigotine Patch Has Favorable Results in Parkinson’s, Restless Legs
- Role of Patent Foramen Ovale Varies in Cryptogenic Strokes
- Robots May Extend Post-Stroke Race
- Risk Factors Identified for Impulse Control Disorders in Parkinson’s
- Rare Brainstem Glioma Doesn’t Stop Former Marine
- Psychosis in Alzheimer’s May Recur After Dropping Risperidone
- Primary Care Docs Unsure When To Refer For Pediatric Epilepsy Surgery
- Pretreatment ASPECTS Reading Affects Stroke Outcomes
- Pregnancy, Contraception Data Highlighted in Epilepsy Registry
- Prediction Rule Targets Side Effects of Antiepileptic Drugs
- Plotting A Better Pathway For Parkinson’s Disease: The My PD Journey Project
- Pilot Program Shows Cardiac Rehab Can Help Poststroke
- Physiotherapy Found to Have Short-Term Benefit in Parkinson’s
- PET/CT Pinpoints Physiological Evidence Of Chemo Brain
- PET Radiotracer Identifies Glioma Treatment Response
- Past & Future Of Stroke Care In Europe
- Parkinson’s Life – A new ‘Webzine’ For The International Parkinson’s Community Now Live!
- Panel Votes Against Hydrocodone Because Of Abuse Potential
- Pain Scales: What to Ponder When Making Your Pick
- Overview Of Treatment In Infantile Spasms
- Oral Relaxin Improves Poststroke Recovery
- Optogenetic Manipulation Of The Cholinergic System: Potential Implications For The Treatment Of Memory Deficits In Alzheimer’s Disease
- Onset Periods of Depression Linked to Different Dementias
- Olfaction in migraine and its psychiatric comorbidities: a narrative review
- Ocular Tremor a Possible Biomarker for Early Parkinson’s Disease
- Occipital Nerve Block For Cluster Headache: Two Thumbs Up
- Novel Stroke Prophylaxis Strategies: When Should Device-Based Cardiac Occlusion Therapies Be Considered?
- Nondrug Interventions Can Improve Dementia Patients’ Lives
- Nocturnal Sleep Boosts Working Memory Training in Parkinson’s
- New Seizure Classifications Challenge Old Ideologies
- New MS Criteria Aim to Simplify Diagnosis
- New Drugs, Devices Edge Toward Clinical Use : New antiepileptic drugs in the pipeline may provide enhanced safety, tolerability, or potency.
- Neuropsychological Data Endorse Preclinical Alzheimer’s
- Neuromelanin MR Imaging In Parkinson’s Disease
- Nearly Half Have No Seizures at 10 Years Postop
- Natural Toxins: Their Roles In Developing PD
- National Plan Aims to Eliminate Alzheimer’s By 2025
- Multiple Sclerosis Does Not Hurt Pregnancy, Birth Outcomes
- Monitoring Antipsychotic Side Effects Infrequent Among Dementia Patients
- Minimizing The Risk Of Hemorrhagic Stroke During Oral Anticoagulant Therapy For Atrial Fibrillation: The Neurologist’s Perspective
- Miniature Neuro-Stimulator Zaps Chronic Cluster Headache
- Migraine With Aura: Aspirin Called Best Prophylaxis
- Metformin Eyed for Lumbar Radiculopathy Pain
- Meta-Analysis: Statins Don’t Prevent Stroke, Death in Women
- Mental Training For Reinstallation Of Motor Programs After Stroke – Fiction Or Science?
- Mechanical Thrombectomy, The Change Is Coming.
- Mechanical Embolectomy Device Cleared for Acute Stroke Treatment
- MCI in Parkinson’s Linked to Frontostriatal Dysfunction
- Maternal Hypertension Ups Infant’s Stroke Risk
- Leaving A Legacy Of Stroke In Europe: A Community Of Dedicated Professionals Is Changing The Face Of Stroke In Europe
- Laquinimod Halted MS Disability But Not Relapses
- Is there A Multiple Sclerosis Epidemic And Is It The Result Of A Plethora Of Etiological Factors Or Of An As Yet Unknown Or Emergent Latent Risk Factor?
- IOM Report on Epilepsy Supports Comprehensive Approach
- Interferon-Beta Fails to Slow the Progression of Disability in MS
- Innovations Driven By Clinical Evidence
- Initiate Interferon Beta-1a Early to Delay Progression to MS
- Infection Correlated With Stroke Risk in Children
- In the Pipeline: Immunotherapy Slows Childhood Gliomas
- Implanted EEG Device Predicts Seizures in Early Study
- IL-7 Level May Mark Interferon Responsiveness
- Ideas and Innovations in Acute Ischaemic Stroke Treatment
- How Does Multiple Sclerosis Progress? Possible Clues Discovered
- Hormonal Contraception Raises Thrombotic Stroke, MI Risk
- High-Tech Stroke Recovery Aids? More Likely Than You May Think
- High-Risk Alzheimer’s Gene Increases Risk Of Other Dementias
- Help Make Real Change Happen For People Living With Dementia – Sign The Glasgow Declaration!
- Greater Costs, Morbidity Among Uncontrolled Epilepsy Patients
- Glutamate From Gliomas Sparks Seizures
- Genome Sequencing Set to Hunt for Alzheimer’s Clues
- Future MS Care: A consensus Statement Of The MS In The 21st Century Steering Group
- Frovatriptan Shown Advantageous In Menstrual Migraine
- Framingham Score Flags MI Risk After Stroke
- Fingolimod Label Advises ECG Monitoring at First Dose
- Filgrastim Fails to Improve Ischemic Stroke Outcomes
- FEBSTAT Study Hints At Predictors Of Epilepsy
- FDA Approves Oral MS Drug Teriflunomide
- Family History Tops Parkinson’s Disease Risk Factors
- Exercise May Be The Best Medicine For Alzheimer’s
- Exercise Improved Some Cognitive Function in Parkinson’s
- European Multiple Sclerosis Platform November 2014 Newsletter
- European Multiple Sclerosis Platform January 2015 Newsletter
- Epilepsy Raises Risk For Sudden Cardiac Arrest
- Epilepsy Incidence High Following Pediatric Stroke
- Epilepsy Incidence High Following Pediatric Stroke
- Environment Modifies ApoE e4-Related Risk of Alzheimer’s Disease
- EMSP’s MS Nurse Pro: Recognizing The Key Role Of MS Nurses
- Elderly Stroke Patients Have High Atrial Fibrillation Prevalence
- Effect of vibrotactile stimulation with cueing on falls in Parkinson’s disease: case study
- Early Surgery Yields Survival Benefit For Low-Grade Gliomas
- Early Surgery Deemed Best for Drug-Resistant Epilepsy
- Early Surgery Deemed Best for Drug-Resistant Epilepsy
- Dysfunctional Brain Areas May Fuel Inattention in Absence Epilepsy
- Drugs Found To Both Prevent And Treat Alzheimer’s Disease In Mice
- Drug For Alzheimer’s, Parkinson’s And MS Shows Promise
- Drug Dosage, Gender Affect Impulsivity Prognosis in Parkinson’s
- Disparities Seen in Care of Parkinson’s Patients : Better clinical care associated with neurologists was often unavailable to women or minorities.
- Depressed Stroke Survivors At Increased Risk Of Death
- Delirium Hits Hard in Hospitalized Alzheimer’s Patients
- CT Perfusion in Acute Stroke Questioned
- Continuing Donepezil Appears Best for Some Alzheimer’s Patients
- Coming Up Next: Managing Motor Complications In Parkinson’s Disease
- CombiRx For MS Not Better Than Monotherapy
- Coffee Consumption Linked to Lower Dementia Risk in Elderly
- CNS Events Not Immediately Fatal in Mantle Cell Lymphomas
- Clinical, Social Barriers Cripple Adequate Alzheimer’s Care
- Chronic Musculo-Skeletal Pain Travels With Chronic Daily Headache
- Chronic Migraine Linked to More Stressful Life Events
- Chemotherapy-Induced Neuropathy Linked to Falls
- Changing the paradigm for treating motor fluctuations in Parkinson’s: advancements in COMT inhibition
- Changing How We Prescribe Antipsychotics for Dementia
- Cerebrospinal Fluid Prognostic Biomarkers In Multiple Sclerosis
- Cavernous Malformation Of Left Basal Ganglia Region In A 12-Year-Old Boy – Case Report.
- Can Lapatinib Prevent Brain Metastases From Breast Cancer? Data ‘Inconclusive’
- Buphenyl Identified As A Possible Drug For Alzheimer’s Disease
- Brain Tumors Glow ‘Like Lava’ With New Surgical Probe
- Botulinum Neurotoxin And Dystonia: A Case For Greater Flexibility In Treatment Regimens?
- Botox May Greatly Reduce Migraine Chronicity
- Botox For Chronic Migraine Brings Cost Savings
- Blood Test May Predict Alzheimer’s in Cognitively Impaired
- Biomarkers May Aid Differential Diagnosis of Dementias, Parkinsonism
- BG-12 Cuts Relapse Rate, Lesions in Multiple Sclerosis
- Benefit of IVIG in Alzheimer’s Disease Appears Durable
- Balloon Angioplasty Improves Venous Flow in MS Patients
- Atrial Fibrailation In Young Stroke Patients
- Antibody Reduces Amyloid-Beta in Alzheimer’s
- An insight into the upcoming ESMINT Annual Meeting – Nice, France 2022
- Amyloid Imaging Agent May Aid Alzheimer’s Diagnosis
- Alzheimer’s Imaging Agent Considered For Medicare Coverage
- Alzheimer’s Drug Misses Primary End Points in Trials
- All Acute Antimigraine Drugs Protect Against Chronic Migraine
- Algorithm May Help Cut PML Risk With Natalizumab
- Air Pollution May Hurt Cognition, Increase Strokes
- Ahead Of The Journals: Discontinuing Risperidone In AD
- Advanced Imaging To Extend The Therapeutic Time Window Of Acute Ischemic Stroke
- Acetyl-l-Carnitine Yields Mixed Results for Chemo-Induced Neuropathy
- A very warm welcome to our new advisory board member – Wolfgang Reith
- A Second Amyloid Could Play A Role In Alzheimer’s Disease
- A Collaborative Initiative To Improve MS Research And Policy Across Europe
- 2014 Joint Actrims-Ectrims Meeting – EMSP Highlights Report
- ‘Scrambler’ Device Reduces Refractory Neuropathic Pain
- ‘Drip and Ship’ Proves Safe for Stroke
All Articles For Psychiatry
- Zolpidem Linked To Higher Inpatient Fall Rates
- We are pleased to announce our most recent media partnership with ESMINT
- Watch for Heavy Smoking in Schizophrenia
- Using SSRIS In Pregnancy
- Tobacco, Drug Use High Early in Course of Schizophrenia
- Titrate ADHD Meds Quickly for Best Outcome
- The Papez circuit in schizophrenia 1: Neuropathological changes
- Suicidality Tied to ‘Self-Disorders’ in Early Schizophrenia
- Substance Abuse ‘Under-appreciated’ Among Elderly Psychiatric Inpatients
- Study Identifies Predictors Of Cognitive Impairment In Schizophrenia
- SSRI Antidepressants Safe For Depressed Epilepsy Patients
- Sleep-Disordered Breathing in Early Childhood Linked With Behavioral Outcomes
- Skimping on Sleep May Increase Stroke Risk
- School Staff Can Aid Treatment of Psychotic Children
- Schizophrenia With Panic Disorder May Be a Distinct Subtype
- Range of Childhood Trauma Linked to Schizophrenia Risk
- Raloxifene Gains Ground as Adjunctive Schizophrenia Treatment
- RAISE: Early Intervention In Schizophrenia Put To The Test
- Phyto-Anxiolytic Effects Of A Fixed Herbal Drug Combination For The Relief Of Stress And Its Potential To Reduce Benzodiazepine Use
- Phone Therapy for Depression Boosts Treatment Adherence
- Persistent Daytime Sleepiness Common Despite Effective CPAP
- Patients At Risk For Psychosis Show Gradual Decrease In Hippocampal Volume
- Pathological changes in the Salience Network in schizophrenia.
- Panel Votes Against Hydrocodone Because Of Abuse Potential
- Oppositional Defiant Disorder Linked to Symptoms of Schizophrenia Spectrum Disorder
- Onset Periods of Depression Linked to Different Dementias
- Olfaction in migraine and its psychiatric comorbidities: a narrative review
- Older Adults With Schizophrenia Can Achieve Remission
- OCD Commonly Precedes Schizophrenia in Men With Both
- Obstructive sleep apnea, oxidative stress and endotelial dysfunction
- Obesity Could Be Treated With Deep Brain Stimulation
- Obesity and diabetes linked to cognitive decline
- Novel Antipsychotic Treats Acute Mania in Bipolar Disorder
- More Evidence Confirms Relevance of Risk Allele to Schizophrenia
- Metformin Resolves Amenorrhea in Antipsychotic-Treated Schizophrenia
- Melatonin May Normalize Night Owl Sleep Schedules
- Medical Comorbidity Affects Disease Course in Bipolar Disorder
- Marijuana Use Linked To Better Adherence In Psychosis
- Marijuana Use Linked To Better Adherence In Psychosis
- Mania With Depressive Symptoms: A Pathophysio-Logical Review
- Liquid, Extended-Release Drug Approved For ADHD
- Lifetime Estrogen Exposure Linked to Depression Risk in Perimenopause
- Levomilnacipran SR Effective for Major Depressive Disorder
- Is My Child ‘Bipolar’?
- Intranasal Oxytocin May Ease Schizophrenia Symptoms
- Intervention For Epilepsy Patients Helped Prevent Depression
- Insomnia, Hypersomnia Disorders Criteria Proposed for DSM-5
- Insomnia Drug Helps Patients Sleep Sooner, Longer
- ICD Shocks Boost Anxiety And Mortality
- Home Sleep Apnea Testing: Wake Up Call for Sleep Docs
- Hoarding Not Related To OCD, New Findings Reveal
- Findings Boost Causal Argument for Smoking, Depression
- FDA Approves Low-Dose Zolpidem for Night Awakening
- FDA Approves First Generic Form of Escitalopram
- Family-Focused Therapy May Help Resistant Pediatric OCD
- Exercise Rivals Sertraline in Comorbid CHD, Depression
- ESRS Sleep Medicine Textbook
- DSM-5 Cleared For Takeoff
- Don’t Overreach For Subthreshold Pediatric Bipolar Disorder
- Depression, Obesity Linked in Older Women but Not Older Men
- Depression May Shorten Survival in Kidney Cancer
- Depression Linked to Unhealthy Dieting Among Women
- Depression Can Be Migraine’s Tipping Point
- Depot Injection Boosts Antipsychotic Compliance in Schizophrenia
- CPAP Improves Mood in Sleep Apnea Patients
- Contemporary Perspectives On Lacanian Theories Of Psychosis
- Computer Training Leads to Lasting Improvements in Schizophrenia
- Combination Therapy Yields Mixed Results for PTSD, Substance Abuse
- Cognitive Therapy Plus Active Monitoring Benefits People at Risk of Psychosis
- C9orf72-Associated Frontotemporal Dementia And Psychosis
- Attention Retraining Enhances CBT For Adolescent Anxiety
- Adjunctive Lithium Reduces Use of Newer Antipsychotics in Bipolar
- A very warm welcome to our new advisory board member – Krassen Nedeltchev
- ‘On-Off’ Switches Shed Light on Brain Disorders : Narcolepsy, cataplexy, and REM sleep behavior disorder linked to errant ‘flip-flop’ mechanisms.
- ‘Mind-Pops’ More Common in Schizophrenia
All Videos For Neurology
- World-Renowned Doctor Heads Neurosurgery Clinic At GEMC
- What is the future for NOACs in secondary prevention of ESUS? – Christina Sjöstrand, Hans-Christoph Diener & George Ntaios
- What Is My Pd Journey?
- Treating motor fluctuations in Parkinson‘s Disease – Prof. Tobias Warnecke
- Transforming stroke care continuum together. A symposium supported and organised by Medtronic, ESO-WSO Virtual Congress 2020
- Three Part Round Table Discussion: Which Techniques To Achieve FPE? Experts Share Their Daily Practice
- Protected: The Novel Oral Anticoagulants For Af…What Do The Sub-Analyses Tell Us?
- The Impact Of Thrombectomy For Stroke Patients In the UK – World Stroke Day 29th October 2022
- The impact of COVID-19 for families with Parkinson’s Disease
- The efficacy of Apomorphine – A non-motor perspective: Prof. K Ray Chaudhuri
- The Diagnosis of Parkinson’s Disease – Dr. Francesca Morgante
- The Angels Initiative: Stroke care taking flight with the wings of Angels – ESO-WSO Virtual Congress 2020
- Tailoring Levodopa according to patient characteristics
- Studies Bolster Alzheimer’s Amyloid Hypothesis
- Sleep Problems May Increase Risk for Dementia
- S2 EP7: ABC of PD – The Letter N (Part 2): Non Motor Symptoms – Apomorphine
- S2 EP6: ABC of PD – The Letter N: Non Motor Symptoms
- S2 EP5: ABC of PD – The Letter O: ON/OFF, On Demand Therapies, Opicapone
- Roundtable discussion, Professors Werner Poewe, Angelo Antonini and Oliver Rascol discuss: “Is Delaying Levodopa a Disservice to Patients?”
- Roundtable Discussion – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention
- Role, Function and Effect of Catechol-O-Methyl Transferase In Humans And Parkinson Disease
- Roche AD Taxi: Biomarkers for the diagnosis of late-stage dementia: Are we there yet? – Dr Diana Kerwin
- Roche AD Taxi: Biomarkers and the AD continuum – Prof. Henrik Zetterberg
- Roche AD Taxi: An introduction to biomarkers in AD – Prof. Henrik Zetterberg
- Rehabilitation In MS
- Reflections on Parkinson’s Disease Podcast – S2 EP4: ABC of PD – The Letter G: GBA and Genetics
- REDEFINING FLOW DIVERSION WITH PIPELINE™ FLEX WITH SHIELD™ TECHNOLOGY: RELEASE OF NEW CLINICAL DATA
- Recognition and Management of Wearing Off Utilisation of Catechol-O-Methyltransferase (COMT) Inhibitors – Olivier Rascol
- RE-SPECT ESUS: Optimizing Prevention of Embolic Stroke of Undetermined Source – Mike Sharma, Richard A. Bernstein & Hans-Christoph Diener
- RE-SPECT ESUS: Dabigatran versus acetylsalicylic acid for stroke prevention in patients with embolic stroke of undetermined source – Hans-Christoph Diener
- Progesterone Quells Some Intractable Catamenial Seizures
- Prof. Dr. István Szikora – Press conference in October on the national stroke imaging network
- Prof. David Devos, MD, PhD Expert opinion on early start of infusion therapies in PD (interview during MDS Congress, Nice, France, 24.09.2019)
- People over the world talk about their Parkinson’s – Chapter 1
- Past And Future Of Stroke Care In Europe – How Can Sits Support?
- Parkinson’s Life podcast: a voice for the global Parkinson’s community. LISTEN TO THE NEW EPISODE 5
- Parkinson’s Disease: An update on basic concepts – Dr Monica Kurtis
- Parkinson’s Disease – Patient Roleplay
- Parenting And MS
- Panel Discusses Direction of Alzheimer’s Disease Research
- Oruen Testimonial by Professor Werner Poewe
- Nonmotor Symptoms In Parkinson’s Disease Recognition & Management
- New Developments In Parkinson’s Disease Management: Interviews With The Experts
- New Developments In Parkinson’s Disease Management: Interviews With The Experts
- Multidisciplinary care in PD – Does it make a difference?
- MS-Optic Neuritis
- MS-Exercise
- MS & Recreation
- MS & Nutrition
- Ms & Nutrition
- Ms & Exercise
- Ms & Education – Optic Neuritis
- MS & Depression
- MS & Dating
- Modulation of Levodopa Metabolism, The Role of COMT Inhibition and Opicapone ▼ Pharmacologic Profile
- Minimizing The Risk Of Haemorrhagic Stroke During Oral Anticoagulant Therapy For Atrial Fibrillation: The Neurologists’ Perspectives
- MicroVention-Terumo symposiums from ESMINT 2022, Nice, France
- Memory Declines Years Before Stroke Strikes
- Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (German)
- Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (English)
- Medical Food, Supplement Appear Helpful for Dementias
- Measurement And Improvement Of Stroke Care, Eso-East
- Managing Bladder & Bowel Issues In MS
- Management of Parkinson’s Disease: From Science to Clinical Wisdom, Prof. Werner Poewe, Prof. Fabrizio Stocchi, Prof. Georg Ebersbach & Dr. Francesca Morgante
- Learnings from the ESUS trials – Jesse Dawson, Martin Grond & Maurizio Paciaroni
- Introduction To The Symposium
- Interview With WSO President: Prof. Michael Brainin
- Interview With MDS President: Prof. Claudia Trenkwalder
- Interview with EMSP President: Prof. Pedro Carrascal
- In-Hospital Management Of Acute Ischaemic Stroke: How Can We Do Better?
- Implementation of Best Practice in Europe: The Angels Initiative – The Role Of ESO
- Gamma Knife Surgery Cuts Seizures in Tumor Patients
- Gamma Knife Surgery Cuts Seizures in Tumor Patients
- Protected: From Studies To Real-Life Evidence…Latest Insights From The Garfield Af Registry
- Federal Funds Launch First Alzheimer’s Prevention Study
- Experimental Drug Improves Cognition, Memory in Alzheimer’s
- Exclusive Interview With ESO President: Prof. Martin Dichgans
- ESOC 2017 Conference News
- ESOC 2017 – Day 2 Highlights
- ESOC 2017 – Day 1 Highlights
- ESO Endorsed Medtronic Webinar: AF screening in Cryptogenic Stroke patients, from guidelines to daily practice – 26th January 2023
- ESC 2014. In-Hospital Management Of Acute Ischaemic Stroke: How Can We Do Better?
- EPDA #UniteForParkinsons
- Embolic Stroke of Undetermined Source (ESUS) – Valeria Caso, Danilo Toni & Martin Grond
- Early vs Late Use Of Levodopa – Angelo Antonini
- Early use of Levodopa vs Levodopa-sparing strategies
- Duloxetine Eases Pain of Chemo-Induced Neuropathy
- Dr Don Frei shares insights about REDglide Difference & discusses ADAPT Technology with Joan Kristensen
- Diagnosis and Management of Wearing Off – Repositioning COMTi and Response Duration in Levodopa Optimisation
- Diagnosis and Management of Levodopa Response Fluctuations in Parkinson’s Disease
- Despite Potential Gains, Patients Balk at Epilepsy Surgery
- Delayed ON And Wearing OFF – Complications
- Cryptogenic Stroke Webinar – ESO-WSO Virtual Congress 2020
- Critical Case Considerations
- Continuous Dopaminergic Stimulation – Dr. Stuart Isaacson
- Clot-Busters Safely Treated Wake-Up Stroke Patients
- Clinical Manifestations, Pathophysiology and Impact of Motor Fluctuations in Patients
- Clinical Data of Opicapone ▼ for the Management of Motor Fluctuations in PD Patients
- CarePartners And MS
- Boehringer Ingelheim: WSC 2018 – secondary stroke prevention: new evidence that demands a verdict
- Boehringer Ingelheim: ESOC 2019 – How NOAC selection and reversal can help protect our patients: Your questions answered
- Boehringer Ingelheim: Angels WSC 2018 – Improving Stroke Care Across The World: The Angels Initiative
- Boehringer Ingelheim: Angels ESOC 2019 – THE ANGELS INITIATIVE: 3 YEARS AND COUNTING
- Boehringer Ingelheim: Actilyse WSC 2018 – New Frontiers in Acute Ischaemic Stroke Reperfusion
- Boehringer Ingelheim ESOC 2018 – Stroke Prevention and Treatment: New Insights Into NOACS and Reversal
- Bayer: ESOC 2019 – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention
- Anticoagulation for Cerebral Venous Thrombosis
- Protected: Anti-Coagulation With Novel Oac’s In Af, Practical Guidance And Interactive Session
- Angels: FAST Heroes: Results of cross-country implementation of a global school-based stroke education campaign – ESOC 2022 Studios
- Angels ESOC 2018 – Experience From Today For The Stroke Care Of The Future
- Anemia Triples Post-Stroke Mortality Risk
- An Introduction to the Pharmacokinetics of Levodopa – Prof. Fabrizio Stocchi
- An alternative treatment to prevent stroke in patients with Atrial Fibrillation: Left Atrial Appendage Occlusion-Latest evidence
- Am Impakt: Apomorphine For Morning Akinesia Trial – Results
- Alive or Dead? Secondary Stroke Prevention with NOACs in ESUS – Ken Butcher
- Adjuvant PCV Chemo Hikes Oligodendroglioma Survival
- A2A Receptor Antagonists: Potential adjuvant therapies for levodopa optimisation
- A testimonial from the ESO past president – Valeria Caso
- A message from the ESO President – Professor Valeria Caso
- 1-2-1 interviews on WEB Study – Dr. Szikora, Dr. Arthur, Prof. Pierot & Propriety X Surface Treatment for Flow Diverter -Dr. Dion
- “I am Cheryl”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia
- “I am David”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia
- ‘Wearing off’ to L-DOPA and its underlying mechanisms
All Videos For Psychiatry
- Treating Childhood Sleep Apnea Improved Cognitive Function
- Treat Comorbid Depression in Breast Cancer Patients
- The International Society Of Affective Disorders
- Sleep Problems May Increase Risk for Dementia
- Schizophrenia Symptoms Linked To Faulty ‘Switch’ In Brain
- Neuropath-Ological Changes In The Nucleus Basalis In Schizophrenia
- Neurochemical Traffic Signals May Open New Avenues For The Treatment Of Schizophrenia
- Interview with ECNP President: Prof. Gitte Moos Knudsen
- Genetic Discoveries May Help Kids With ADHD, Expert Says
- Depressed RA Patients More Likely To Die, Especially Men
- Cancer More Common in People With Sleep Apnea
- An Introduction To The Substantia Nigra In Schizophrenia
- An Introduction To The Putamen In Schizophrenia
- An Introduction To The Nucleus Accumbens In Schizophrenia
- An Introduction To The Caudate In Schizophrenia
Alzheimer's Disease
- What’s the connection between sleep and Alzheimer’s disease? | Sleeping with Science
- Uncontrolled Hypertension Could Bring Increased Risk For Alzheimer’s Disease
- Ten Warning Signs of Alzheimer’s Disease
- Ten Tips for Preventing Alzheimer’s Disease
- Study Suggests New Potential Alzheimer’s Treatment Strategy
- Studies Identify Early Changes In Familial Alzheimer’s Disease
- Studies Bolster Alzheimer’s Amyloid Hypothesis
- Sleep Problems May Increase Risk for Dementia
- Skin Cancer Drug Steps Into New Alzheimer’s Study
- Roche AD Taxi: How can we support primary care physicians with an AD diagnosis? – Dr Diana Kerwin
- Roche AD Taxi: Biomarkers for the diagnosis of late-stage dementia: Are we there yet? – Dr Diana Kerwin
- Roche AD Taxi: Biomarkers and the AD continuum – Prof. Henrik Zetterberg
- Roche AD Taxi: An introduction to biomarkers in AD – Prof. Henrik Zetterberg
- Psychosis in Alzheimer’s May Recur After Dropping Risperidone
- Panel Discusses Direction of Alzheimer’s Disease Research
- Optogenetic Manipulation Of The Cholinergic System: Potential Implications For The Treatment Of Memory Deficits In Alzheimer’s Disease
- Onset Periods of Depression Linked to Different Dementias
- Nondrug Interventions Can Improve Dementia Patients’ Lives
- New Alzheimer Europe report identifies key recommendations on legal capacity and decision making of people with dementia
- Neuropsychological Data Endorse Preclinical Alzheimer’s
- National Plan Aims to Eliminate Alzheimer’s By 2025
- Monitoring Antipsychotic Side Effects Infrequent Among Dementia Patients
- Medical Food, Supplement Appear Helpful for Dementias
- Living with Alzheimer’s disease
- High-Risk Alzheimer’s Gene Increases Risk Of Other Dementias
- Help Make Real Change Happen For People Living With Dementia – Sign The Glasgow Declaration!
- Genome Sequencing Set to Hunt for Alzheimer’s Clues
- Federal Funds Launch First Alzheimer’s Prevention Study
- Experimental Drug Improves Cognition, Memory in Alzheimer’s
- Exercise May Be The Best Medicine For Alzheimer’s
- Environment Modifies ApoE e4-Related Risk of Alzheimer’s Disease
- During greatest public health crisis in living memory, European Commission adopts first Work Plan of new EU4Health Programme undermining key activities of European health NGOs
- Drugs Found To Both Prevent And Treat Alzheimer’s Disease In Mice
- Delirium Hits Hard in Hospitalized Alzheimer’s Patients
- Continuing Donepezil Appears Best for Some Alzheimer’s Patients
- Coffee Consumption Linked to Lower Dementia Risk in Elderly
- Clinical, Social Barriers Cripple Adequate Alzheimer’s Care
- Changing How We Prescribe Antipsychotics for Dementia
- Buphenyl Identified As A Possible Drug For Alzheimer’s Disease
- Blood Test May Predict Alzheimer’s in Cognitively Impaired
- Biomarkers May Aid Differential Diagnosis of Dementias, Parkinsonism
- Benefit of IVIG in Alzheimer’s Disease Appears Durable
- Avatar image Ageing and Alzheimer’s disease: the search for the cure
- Antibody Reduces Amyloid-Beta in Alzheimer’s
- Amyloid Imaging Agent May Aid Alzheimer’s Diagnosis
- Alzheimer’s Disease: What You Need to Know – The #COVID19 Edition
- Alzheimer’s Imaging Agent Considered For Medicare Coverage
- Alzheimer’s Drug Misses Primary End Points in Trials
- Alzheimer Europe sets out recommendations to improve data sharing in dementia research
- Alzheimer Europe publishes two new reports: One on sex, gender and sexuality in the context of dementia, and one on dementia-inclusive initiatives and communities
- Alzheimer Europe position regarding the prioritisation of people with dementia for COVID-19 vaccination
- Alzheimer Europe hosts European Parliament Lunch Debate examining EU and WHO policies on neurological conditions
- Alzheimer Europe 2020 Conference, Opening & Roundtable discussion: Dementia in a changing world
- Alzheimer Europe 2020 Conference Round table discussion: Maintaining dementia as a European priority
- Alzheimer Europe 2020 Conference – Special symposium – My second new life: adapting after COVID-19
- Alzheimer disease – an Osmosis Preview
- Ahead Of The Journals: Discontinuing Risperidone In AD
- A very warm welcome to our new advisory board member – Wolfgang Reith
- A Second Amyloid Could Play A Role In Alzheimer’s Disease
- 17-19 October: 32nd Alzheimer Europe Conference takes place in Bucharest and online under the banner “Building bridges”, bringing together 544 participants from 42 countries
- “Resilience in dementia: Moving beyond the COVID-19 pandemic” brings together over 600 participants from 38 countries
Anxiety
- The Science of Anxiety
- The International Society Of Affective Disorders
- Rewiring the Anxious Brain – Neuroplasticity and the Anxiety Cycle
- Phyto-Anxiolytic Effects Of A Fixed Herbal Drug Combination For The Relief Of Stress And Its Potential To Reduce Benzodiazepine Use
- Neuroscience of Anxiety
- ICD Shocks Boost Anxiety And Mortality
- FDA Approves First Generic Form of Escitalopram
- Attention Retraining Enhances CBT For Adolescent Anxiety
Bipolar Disorder
- The International Society Of Affective Disorders
- The Brain Circuitry of Bipolar Disorder: A View from Brain Scanning Research
- Novel Antipsychotic Treats Acute Mania in Bipolar Disorder
- Neurobiology of Major Depressive Disorder and Bipolar Disorder
- Medical Comorbidity Affects Disease Course in Bipolar Disorder
- Mania With Depressive Symptoms: A Pathophysio-Logical Review
- Is My Child ‘Bipolar’?
- Don’t Overreach For Subthreshold Pediatric Bipolar Disorder
- Bipolar disorder (depression & mania) – causes, symptoms, treatment & pathology
- Adjunctive Lithium Reduces Use of Newer Antipsychotics in Bipolar
- A very warm welcome to our new advisory board member – Krassen Nedeltchev
Brain Complications
Chiropractic Neurology
CME
- Treating motor fluctuations in Parkinson‘s Disease – Prof. Tobias Warnecke
- The role of on-demand medications in Parkinson’s Disease – Prof. Joaquim Ferreira, Prof. Angelo Antonini & Dr Susan Fox
- The impact of COVID-19 for families with Parkinson’s Disease
- The Diagnosis of Parkinson’s Disease – Dr. Francesca Morgante
- Tailoring Levodopa according to patient characteristics
- Pharmacodynamics of levodopa in the pathophysiology of fluctuations in Parkinson’s disease – Prof. Fabrizio Stocchi
- Parkinson’s Disease: An update on basic concepts – Dr Monica Kurtis
- Parkinson’s Disease – Patient Roleplay
- NOACs in Secondary Stroke Prevention – Robin Lemmens, Ales Tomek & Milan R. Voško
- Multidisciplinary care in PD – Does it make a difference?
- Levodopa Mythology – Dr Alberto Espay
- Involving PD patients in their treatment management: Expert discussion: Prof Bas Bloem & Dr Margherita Fabbri
- An alternative treatment to prevent stroke in patients with Atrial Fibrillation: Left Atrial Appendage Occlusion-Latest evidence
- ‘Wearing off’ to L-DOPA and its underlying mechanisms
Depression
- We are pleased to announce our most recent media partnership with ESMINT
- Using SSRIS In Pregnancy
- Treat Comorbid Depression in Breast Cancer Patients
- The International Society Of Affective Disorders
- SSRI Antidepressants Safe For Depressed Epilepsy Patients
- Physical Symptoms of Depression
- Phone Therapy for Depression Boosts Treatment Adherence
- Onset Periods of Depression Linked to Different Dementias
- Lifetime Estrogen Exposure Linked to Depression Risk in Perimenopause
- Levomilnacipran SR Effective for Major Depressive Disorder
- Intervention For Epilepsy Patients Helped Prevent Depression
- How to Help Someone Who’s Lonely, Isolated, or Depressed
- Findings Boost Causal Argument for Smoking, Depression
- FDA Approves First Generic Form of Escitalopram
- Exercise Rivals Sertraline in Comorbid CHD, Depression
- Epilepsy and Mental Health: What You Should Know
- DSM-5 Cleared For Takeoff
- Depression vs Low Grade Depression: The Differences You Should Know
- Depression May Shorten Survival in Kidney Cancer
- Depression Linked to Unhealthy Dieting Among Women
- Depression Can Be Migraine’s Tipping Point
- Depression and Sleep
- Depressed RA Patients More Likely To Die, Especially Men
- Behavior Changes During Depression
Epilepsy
- What Really Causes Epilepsy?
- What is Epilepsy?
- What is Epilepsy and How is it Treated?
- What does the new information on using epilepsy medication during pregnancy mean?
- Welcome Message From The Co-Chairs Of The International Scientific And Organising Committee
- Trauma-Induced Epilepsy May Be Prevented By Cooling The Brain Following Injury
- Study Finds Long-Term Benefits Of DBS In Refractory Epilepsy
- Sleep and Epilepsy (Wellness Institute Whiteboard Video Series)
- Progesterone Quells Some Intractable Catamenial Seizures
- Primary Care Docs Unsure When To Refer For Pediatric Epilepsy Surgery
- Pregnancy, Contraception Data Highlighted in Epilepsy Registry
- Prediction Rule Targets Side Effects of Antiepileptic Drugs
- Overview Of Treatment In Infantile Spasms
- New Seizure Classifications Challenge Old Ideologies
- New Drugs, Devices Edge Toward Clinical Use : New antiepileptic drugs in the pipeline may provide enhanced safety, tolerability, or potency.
- Nearly Half Have No Seizures at 10 Years Postop
- IOM Report on Epilepsy Supports Comprehensive Approach
- Implanted EEG Device Predicts Seizures in Early Study
- Greater Costs, Morbidity Among Uncontrolled Epilepsy Patients
- Glutamate From Gliomas Sparks Seizures
- Gamma Knife Surgery Cuts Seizures in Tumor Patients
- FEBSTAT Study Hints At Predictors Of Epilepsy
- Epilepsy research: MRI | NHS
- Epilepsy Raises Risk For Sudden Cardiac Arrest
- Epilepsy Incidence High Following Pediatric Stroke
- Epilepsy and Mental Health: What You Should Know
- Early Surgery Deemed Best for Drug-Resistant Epilepsy
- Dysfunctional Brain Areas May Fuel Inattention in Absence Epilepsy
Headache/Migraine
- What are Migraines?
- Weighing Botox’s Migraine Benefits Against Costs
- Visual stress: origins and treatment
- Secondary Headaches Flag Medical Conditions in Pregnancy
- Olfaction in migraine and its psychiatric comorbidities: a narrative review
- Occipital Nerve Block For Cluster Headache: Two Thumbs Up
- Miniature Neuro-Stimulator Zaps Chronic Cluster Headache
- Migraines – Pathophysiology & Treatment (Described Concisely)
- Migraine With Aura: Aspirin Called Best Prophylaxis
- Migraine and Headache – Ask Dr. Ailani
- Migraine | Migraine Relief Treatment
- Managing Migraine Headaches
- Get Rid of Migraines Naturally and Fast!
- Frovatriptan Shown Advantageous In Menstrual Migraine
- Diagnosis and Management of Headache
- Chronic Migraine Linked to More Stressful Life Events
- Botox May Greatly Reduce Migraine Chronicity
- Botox For Chronic Migraine Brings Cost Savings
- All Acute Antimigraine Drugs Protect Against Chronic Migraine
Home video
- What is the future for NOACs in secondary prevention of ESUS? – Christina Sjöstrand, Hans-Christoph Diener & George Ntaios
- Treating motor fluctuations in Parkinson‘s Disease – Prof. Tobias Warnecke
- Three Part Round Table Discussion: Which Techniques To Achieve FPE? Experts Share Their Daily Practice
- The role of on-demand medications in Parkinson’s Disease – Prof. Joaquim Ferreira, Prof. Angelo Antonini & Dr Susan Fox
- The Impact Of Thrombectomy For Stroke Patients In the UK – World Stroke Day 29th October 2022
- The impact of COVID-19 on Hemorrhagic Procedures
- The impact of COVID-19 for families with Parkinson’s Disease
- The efficacy of Apomorphine – A non-motor perspective: Prof. K Ray Chaudhuri
- The Diagnosis of Parkinson’s Disease – Dr. Francesca Morgante
- Tailoring Levodopa according to patient characteristics
- Roundtable discussion, Professors Werner Poewe, Angelo Antonini and Oliver Rascol discuss: “Is Delaying Levodopa a Disservice to Patients?”
- Roundtable Discussion – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention
- Role, Function and Effect of Catechol-O-Methyl Transferase In Humans And Parkinson Disease
- Roche AD Taxi: How can we support primary care physicians with an AD diagnosis? – Dr Diana Kerwin
- Roche AD Taxi: Biomarkers for the diagnosis of late-stage dementia: Are we there yet? – Dr Diana Kerwin
- Roche AD Taxi: Biomarkers and the AD continuum – Prof. Henrik Zetterberg
- Roche AD Taxi: An introduction to biomarkers in AD – Prof. Henrik Zetterberg
- REDEFINING FLOW DIVERSION WITH PIPELINE™ FLEX WITH SHIELD™ TECHNOLOGY: RELEASE OF NEW CLINICAL DATA
- Recognition and Management of Wearing Off Utilisation of Catechol-O-Methyltransferase (COMT) Inhibitors – Olivier Rascol
- RE-SPECT ESUS: Optimizing Prevention of Embolic Stroke of Undetermined Source – Mike Sharma, Richard A. Bernstein & Hans-Christoph Diener
- RE-SPECT ESUS: Dabigatran versus acetylsalicylic acid for stroke prevention in patients with embolic stroke of undetermined source – Hans-Christoph Diener
- Prof. Dr. István Szikora – Press conference in October on the national stroke imaging network
- Prof. David Devos, MD, PhD Expert opinion on early start of infusion therapies in PD (interview during MDS Congress, Nice, France, 24.09.2019)
- Prof. Angelo Antonini, MD, PhD – MDS Congress Madrid 2022
- Pharmacodynamics of levodopa in the pathophysiology of fluctuations in Parkinson’s disease – Prof. Fabrizio Stocchi
- Parkinson’s Disease: An update on basic concepts – Dr Monica Kurtis
- Parkinson’s Disease – Patient Roleplay
- Oruen Testimonial by Professor Werner Poewe
- Oruen Testimonial by Dr. Monica Kurtis
- Nonmotor Symptoms In Parkinson’s Disease Recognition & Management
- NOACs in Secondary Stroke Prevention – Robin Lemmens, Ales Tomek & Milan R. Voško
- Multidisciplinary care in PD – Does it make a difference?
- Modulation of Levodopa Metabolism, The Role of COMT Inhibition and Opicapone ▼ Pharmacologic Profile
- MicroVention-Terumo symposiums from ESMINT 2022, Nice, France
- Medtronic – Webinar Session: AVM Treatment
- Medtronic – Webinar Session: Aneurysm Treatment – Flow Diversion Complex Cases
- Medtronic – The Importance of Thrombectomy
- Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (German)
- Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (English)
- Medtronic – Acute Ischemic Stroke Launch Symposium
- Management of Parkinson’s Disease: From Science to Clinical Wisdom, Prof. Werner Poewe, Prof. Fabrizio Stocchi, Prof. Georg Ebersbach & Dr. Francesca Morgante
- Levodopa Mythology – Dr Alberto Espay
- Learnings from the ESUS trials – Jesse Dawson, Martin Grond & Maurizio Paciaroni
- Involving PD patients in their treatment management: Expert discussion: Prof Bas Bloem & Dr Margherita Fabbri
- Interview with the President of the ESMINT 2022 Annual Meeting – Dr Mohamed Aggour
- ESOC 2019 – MEDTRONIC CARE CONTINUUM: Improving Patient Pathway
- ESO Endorsed Medtronic Webinar: Cryptogenic Stroke Patients Need Answers: AF Screening Strategies & Patient Stratification
- ESO Endorsed Medtronic Webinar: AF screening in Cryptogenic Stroke patients, from guidelines to daily practice – 26th January 2023
- Embolic Stroke of Undetermined Source (ESUS) – Valeria Caso, Danilo Toni & Martin Grond
- Early vs Late Use Of Levodopa – Angelo Antonini
- Early use of Levodopa vs Levodopa-sparing strategies
- Dr Don Frei shares insights about REDglide Difference & discusses ADAPT Technology with Joan Kristensen
- Diagnosis and Management of Wearing Off – Repositioning COMTi and Response Duration in Levodopa Optimisation
- Diagnosis and Management of Levodopa Response Fluctuations in Parkinson’s Disease
- Continuous Dopaminergic Stimulation – Dr. Stuart Isaacson
- Clinical Manifestations, Pathophysiology and Impact of Motor Fluctuations in Patients
- Clinical Data of Opicapone ▼ for the Management of Motor Fluctuations in PD Patients
- Charco Neurotech – CUE1: Prof. James Kilner
- Boehringer Ingelheim: WSC 2018 – secondary stroke prevention: new evidence that demands a verdict
- Boehringer Ingelheim: ESOC 2019 – How NOAC selection and reversal can help protect our patients: Your questions answered
- Boehringer Ingelheim: Angels WSC 2018 – Improving Stroke Care Across The World: The Angels Initiative
- Boehringer Ingelheim: Angels ESOC 2019 – THE ANGELS INITIATIVE: 3 YEARS AND COUNTING
- Boehringer Ingelheim: Actilyse WSC 2018 – New Frontiers in Acute Ischaemic Stroke Reperfusion
- Boehringer Ingelheim ESOC 2018 – Stroke Prevention and Treatment: New Insights Into NOACS and Reversal
- Bayer: ESOC 2019 – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention
- Angels: FAST Heroes: Results of cross-country implementation of a global school-based stroke education campaign – ESOC 2022 Studios
- Angels ESOC 2018 – Experience From Today For The Stroke Care Of The Future
- An Introduction to the Pharmacokinetics of Levodopa – Prof. Fabrizio Stocchi
- An alternative treatment to prevent stroke in patients with Atrial Fibrillation: Left Atrial Appendage Occlusion-Latest evidence
- Alzheimer Europe 2020 Conference Round table discussion: Maintaining dementia as a European priority
- Alive or Dead? Secondary Stroke Prevention with NOACs in ESUS – Ken Butcher
- A2A Receptor Antagonists: Potential adjuvant therapies for levodopa optimisation
- A testimonial from the ESO past president – Valeria Caso
- 1-2-1 interviews on WEB Study – Dr. Szikora, Dr. Arthur, Prof. Pierot & Propriety X Surface Treatment for Flow Diverter -Dr. Dion
- ‘Wearing off’ to L-DOPA and its underlying mechanisms
Latest Articles
- X Surface Treatment: The Latest Advancement in Flow Diversion Technology
- Visual stress: origins and treatment
- Updates from Industry and New Technology Symposia, Friday 9th September, 2022 in Nice, France: 14th Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT)
- Transforming the stroke care continuum together
- The Papez circuit in schizophrenia 1: Neuropathological changes
- The honeymoon’s over: what next for people with Parkinson’s?
- The Evolving Endovascular Therapy Toolkit: Real-World and Clinical Experiences with Pipeline Flex and Vantage with Shield Technology and Solitaire X 3 mm
- The changing world of innovative stroke treatment
- Survival After In-Hospital Cardiac Arrest Has Improved Substantially
- Studies Identify Early Changes In Familial Alzheimer’s Disease
- Stroke care taking flight with the wings of ANGELS
- Secondary Stroke Prevention: Who Can Benefit from Device Therapies?
- Prioritising high risk stroke patients for cardiac monitoring
- Pathological changes in the Salience Network in schizophrenia.
- Olfaction in migraine and its psychiatric comorbidities: a narrative review
- Novel Occipital Neuralgia Treatment Addresses C-1 Nerve
- Ideas and Innovations in Acute Ischaemic Stroke Treatment
- Genetic Discoveries May Help Kids With ADHD, Expert Says
- Establishing stroke systems of care from the bottom to the top: A global perspective
- Effect of vibrotactile stimulation with cueing on falls in Parkinson’s disease: case study
- Current Digital Applications in Psychiatry, Specifically ADHD
- Changing the paradigm for treating motor fluctuations in Parkinson’s: advancements in COMT inhibition
- An update of opicapone in Parkinson’s disease: evidence-based results of recent trials
- Alzheimer’s Imaging Agent Considered For Medicare Coverage
Latest News
- We are pleased to announce our most recent media partnership with ESMINT
- VIEW LATEST ISSUE: Oruen – The CNS Journal (Vol. 5, Issue 2 – Dec 2019)
- Uncontrolled Hypertension Could Bring Increased Risk For Alzheimer’s Disease
- Trauma-Induced Epilepsy May Be Prevented By Cooling The Brain Following Injury
- Thrombectomy technique choices
- The European Stroke Organisation (ESO) is delighted to be running the 9th ESO Conference (ESOC) 2023 on 24th – 26th May 2023 in Munich, Germany
- The Angels Initiative at ESOC 2021
- The Alzheimer Europe Magazine: Dementia in Europe issue 33 published as an e-magazine
- The 5th annual European Stroke Organisation Conference (ESOC) – Media Releases
- Study Identifies Predictors Of Cognitive Impairment In Schizophrenia
- Stroke Action Plan for Europe (SAP-E) Implementing together Stroke Care in Europe
- Second day of virtual Alzheimer Europe Conference “Dementia in a changing world” focuses on diagnosis and medical management and on dementia–inclusive societies
- SEASON 2 EPISODE 1 OUT NOW: Reflections on Parkinson’s Disease Podcast by Professor Bas Bloem and Professor Werner Poewe
- SAFE Launches A Website For Stroke Prevention
- Registrations are open for the 33rd Alzheimer Europe Conference #33AEC!
- Prof. Teus van Laar joins Oruen Advisory Board
- Prof. Paolo Machi joins Oruen Advisory Board
- Prof. Olivier Rascol joins Oruen Advisory Board
- Prof. Joaquim Ferreira joins Oruen Advisory Board
- People over the world talk about their Parkinson’s – Chapter 1
- Parkinson’s Life podcast: a voice for the global Parkinson’s community. LISTEN TO THE NEW EPISODE 5
- Oruen The CNS Journal – Volume 5 Issue 1 (July 2019) Current Issue NOW PUBLISHED
- Oruen The CNS Journal – Volume 4 Issue 2 (December 2018) Current Issue
- Oruen The CNS Journal – Volume 4 Issue 1
- Oruen Testimonial by Professor Werner Poewe
- New Alzheimer Europe report identifies key recommendations on legal capacity and decision making of people with dementia
- MULTIPLE SCLEROSIS (MS): EUROPEAN CONFERENCE CALLS FOR INCREASED FOCUS ON PROGRESSIVE MS
- MULTIPLE SCLEROSIS (MS): EUROPEAN CONFERENCE CALLS FOR INCREASED FOCUS ON PROGRESSIVE MS
- Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
- Life after stroke – what is the problem?
- Kids Get MS, too – National MS Society
- Interview With WSO President: Prof. Michael Brainin
- Interview With MDS President: Prof. Claudia Trenkwalder
- Interview with EMSP President: Prof. Pedro Carrascal
- Interview with ECNP President: Prof. Gitte Moos Knudsen
- Interested in the EANS Training Courses? Apply now for the 2021 entry!
- Hot Topics in Obstructive Sleep Apnea – A European View
- Full costs of stroke in 32 European countries is €60 billion
- Final day of Alzheimer Europe’s first ever virtual conference focuses on moving from research and innovation to clinical and care practice, and on dementia as a European priority
- Exclusive Interview With ESO President: Prof. Martin Dichgans
- European WAKE-UP trial shows benefit of thrombolysis in stroke with unknown time of onset
- ESRS Celebrates certification of more than 1100 Somnologists and Somnologist Technologists
- ESOC 2021: Shaping the future
- ESO And SAFE Kick-Off The Implementation Of The Stroke Action Plan For Europe (SAP-E) – A Major Initiative To Reduce The Burden Of Stroke In Europe
- ESO & S.A.F.E – Declaration for Action on Stroke launches on European Stroke Awareness Day
- ESO / SAFE Press Release: Ukraine signs the Stroke Action Plan for Europe Declaration
- ESMINT PRESS RELEASE: Prof Dr Christian Taschner appointed to the European Commission’s Medical Devices Expert Panel
- ESMINT 11th Congress Impact Report 2019
- EPND: New European initiative will build a collaborative platform for data and sample sharing, to accelerate the discovery and validation of biomarkers for neurodegenerative diseases
- EPDA survey on drooling (sialorrhea) in Parkinson’s
- eEANS2021 Virtual Congress: 3rd October – 7th October 2021
- Educating And Enhancing The Role Of Belgian MS Nurses
- EANS2022 Abstract Submission is now open!
- EANS 2022 Belgrade Congress: An event to remember!
- EANS 2020: The 20th European Congress of Neurosurgery goes virtual – Register Here!
- e-Journal Vol 7 Issue 2 (Jan 2022) Out Now!
- e-Journal Vol 7 Issue 1 (Aug 2021) Out Now!
- e-Journal Vol 6 (Jan 2021) Out Now!
- During greatest public health crisis in living memory, European Commission adopts first Work Plan of new EU4Health Programme undermining key activities of European health NGOs
- Dr. Mohamed Aggour joins Oruen Advisory Board
- Dr. Margherita Fabbri joins Oruen Advisory Board
- Dr Sanjeev Nayak joins Oruen Advisory Board
- Deep Brain Stimulation Might Help Early In Parkinson’s
- An update on innovative stroke treatment
- An insight into the upcoming ESMINT Annual Meeting – Nice, France 2022
- Alzheimer Europe supports the rights and dignity of people with dementia with three new publications, looking at employment and social protection, at sex, gender and sexuality and at ethical communication
- Alzheimer Europe sets out recommendations to improve data sharing in dementia research
- Alzheimer Europe rings the alarm about discriminatory practices in intensive care settings during the COVID-19 pandemic
- Alzheimer Europe publishes two new reports: One on sex, gender and sexuality in the context of dementia, and one on dementia-inclusive initiatives and communities
- Alzheimer Europe position regarding the prioritisation of people with dementia for COVID-19 vaccination
- Alzheimer Europe outlines state-of-play of dementia policy in Europe
- Alzheimer Europe lunch debate focuses on dealing with behavioural and psychological symptoms (BPSD) in dementia care
- Alzheimer Europe calls for urgent action to address the impact of COVID-19 on dementia research
- Alzheimer Europe Board adopts recommendations on how to promote the wellbeing of people with dementia and carers during the COVID-19 pandemic
- Always a good time to learn about stroke prevention
- A Very Warm Welcome To Our New Advisory Board Member – Prof. George Ntaios
- A Very Warm Welcome To Our New Advisory Board Member – Peter Wolf
- A very warm welcome to our new advisory board member – Wolfgang Reith
- A very warm welcome to our new advisory board member – Prof. Mario Martínez-Galdámez
- A very warm welcome to our new advisory board member – Krassen Nedeltchev
- A Very Warm Welcome To Our New Advisory Board Member – Hans-Christoph Diener
- A Very Warm Welcome To Our New Advisory Board Member – Graeme Hankey
- A Very Warm Welcome To Our New Advisory Board Member – Angelo Antonini
- A Very Warm Welcome To Our Latest Addition To The Advisory Board
- A Very Warm Welcome To Our Latest Addition To The Advisory Board
- A Very Warm Welcome To Our Latest Addition To The Advisory Board
- A very warm welcome to our latest addition to the Advisory Board
- A very warm welcome to our latest addition to the Advisory Board
- A Very warm welcome to our latest addition to the Advisory Board
- A Very Warm Welcome To Our Latest Addition To The Advisory Board
- A testimonial from the ESO past president – Valeria Caso
- A successful collaboration between SAFE and the ANGELS Initiative helps improving patient – doctor communication
- 30th Alzheimer Europe Virtual Conference “Dementia in a changing world” brings together almost 800 participants from 42 countries
- 30th Alzheimer Europe Conference #30AEC goes virtual!
- 17-19 October: 32nd Alzheimer Europe Conference takes place in Bucharest and online under the banner “Building bridges”, bringing together 544 participants from 42 countries
- “Resilience in dementia: Moving beyond the COVID-19 pandemic” brings together over 600 participants from 38 countries
Movement Disorders
- What’s New In Parkinson’s Rating Scales?
- What to do when the honeymoon wears off
- What Is My Pd Journey?
- Weight Lifting Improves Physical Function in Parkinson’s
- Voice Disturbance Analysis Detects Parkinson’s
- Treatment Options For Atypical Parkin-Sonisms
- Treating motor fluctuations in Parkinson‘s Disease – Prof. Tobias Warnecke
- The role of on-demand medications in Parkinson’s Disease – Prof. Joaquim Ferreira, Prof. Angelo Antonini & Dr Susan Fox
- The Role Of Apomorphine In The Effective Management Of Parkinson’S Disease – Highlights From Cony 2014
- The Next Frontier for Parkinson’s disease and Movement Disorders: The Middle East, North Africa and South Asia (MENASA) region
- The impact of COVID-19 for families with Parkinson’s Disease
- The honeymoon’s over: what next for people with Parkinson’s?
- The efficacy of Apomorphine – A non-motor perspective: Prof. K Ray Chaudhuri
- The Diagnosis of Parkinson’s Disease – Dr. Francesca Morgante
- The Clinical Validation Of Objective Measurement Of Movement In Parkinson’s Disease
- Tailoring Levodopa according to patient characteristics
- Tai Chi Improved Postural Stability in Parkinson’s Disease
- Symptom Triad May Identify Parkinson’s Risk
- Study Hints at Statins’ Protective Effect Against Parkinson’s
- S2 EP7: ABC of PD – The Letter N (Part 2): Non Motor Symptoms – Apomorphine
- S2 EP5: ABC of PD – The Letter O: ON/OFF, On Demand Therapies, Opicapone
- Roundtable discussion, Professors Werner Poewe, Angelo Antonini and Oliver Rascol discuss: “Is Delaying Levodopa a Disservice to Patients?”
- Rotigotine Patch Has Favorable Results in Parkinson’s, Restless Legs
- Role, Function and Effect of Catechol-O-Methyl Transferase In Humans And Parkinson Disease
- Risk Factors Identified for Impulse Control Disorders in Parkinson’s
- Reflections on Parkinson’s Disease Podcast – S2 EP4: ABC of PD – The Letter G: GBA and Genetics
- Reflections on Parkinson’s Disease Podcast – S2 EP3: ABC of PD – The Letter F: Fluctuations & Fatigue
- Reflections on Parkinson’s Disease Podcast – S2 EP2: ABC of PD – The Letter E: Early Morning Off, Evidence, Exercise, Early PD
- Reflections on Parkinson’s Disease Podcast – S2 EP1: ABC of PD – The Letter C: COMT Inhibitors, Continuous Dopaminergic Delivery
- Reflections on Parkinson’s Disease Podcast – EP7: Apomorphine and non-motor symptoms
- Reflections on Parkinson’s Disease Podcast – EP6: Talking PD – Issues in doctor-patient communication
- Reflections on Parkinson’s Disease Podcast – EP5: The Hardships Of Being Off
- Reflections on Parkinson’s Disease Podcast – EP4: Response Fluctuations in Parkinson’s Disease and why they can be missed
- Reflections on Parkinson’s Disease Podcast – EP3: Why PD patients start to fluctuate
- Reflections on Parkinson’s Disease Podcast – EP2: Motor Fluctuations and the levodopa long-duration response
- Reflections on Parkinson’s Disease Podcast – EP1: Levodopa Facts and Myths
- Recognition and Management of Wearing Off Utilisation of Catechol-O-Methyltransferase (COMT) Inhibitors – Olivier Rascol
- Prof. David Devos, MD, PhD Expert opinion on early start of infusion therapies in PD (interview during MDS Congress, Nice, France, 24.09.2019)
- Prof. Angelo Antonini, MD, PhD – MDS Congress Madrid 2022
- Plotting A Better Pathway For Parkinson’s Disease: The My PD Journey Project
- Physiotherapy Found to Have Short-Term Benefit in Parkinson’s
- Pharmacodynamics of levodopa in the pathophysiology of fluctuations in Parkinson’s disease – Prof. Fabrizio Stocchi
- People over the world talk about their Parkinson’s – Chapter 1
- Parkinson’s Life – A new ‘Webzine’ For The International Parkinson’s Community Now Live!
- Parkinson’s Life podcast: a voice for the global Parkinson’s community. LISTEN TO THE NEW EPISODE 5
- Parkinson’s Disease: An update on basic concepts – Dr Monica Kurtis
- Parkinson’s Disease – Patient Roleplay
- Oruen Testimonial by Professor Werner Poewe
- Oruen Testimonial by Dr. Monica Kurtis
- Ocular Tremor a Possible Biomarker for Early Parkinson’s Disease
- Nonmotor Symptoms In Parkinson’s Disease Recognition & Management
- Nocturnal Sleep Boosts Working Memory Training in Parkinson’s
- New Developments In Parkinson’s Disease Management: Interviews With The Experts
- New Developments In Parkinson’s Disease Management: Interviews With The Experts
- Neuromelanin MR Imaging In Parkinson’s Disease
- Natural Toxins: Their Roles In Developing PD
- Multidisciplinary care in PD – Does it make a difference?
- Modulation of Levodopa Metabolism, The Role of COMT Inhibition and Opicapone ▼ Pharmacologic Profile
- MCI in Parkinson’s Linked to Frontostriatal Dysfunction
- Management of Parkinson’s Disease: From Science to Clinical Wisdom, Prof. Werner Poewe, Prof. Fabrizio Stocchi, Prof. Georg Ebersbach & Dr. Francesca Morgante
- Levodopa Mythology – Dr Alberto Espay
- Involving PD patients in their treatment management: Expert discussion: Prof Bas Bloem & Dr Margherita Fabbri
- Introduction To The Symposium
- Family History Tops Parkinson’s Disease Risk Factors
- Exercise Improved Some Cognitive Function in Parkinson’s
- EPDA #UniteForParkinsons
- Effect of vibrotactile stimulation with cueing on falls in Parkinson’s disease: case study
- Early vs Late Use Of Levodopa – Angelo Antonini
- Early use of Levodopa vs Levodopa-sparing strategies
- Drug For Alzheimer’s, Parkinson’s And MS Shows Promise
- Drug Dosage, Gender Affect Impulsivity Prognosis in Parkinson’s
- Disparities Seen in Care of Parkinson’s Patients : Better clinical care associated with neurologists was often unavailable to women or minorities.
- Diagnosis and Management of Wearing Off – Repositioning COMTi and Response Duration in Levodopa Optimisation
- Diagnosis and Management of Levodopa Response Fluctuations in Parkinson’s Disease
- Delayed ON And Wearing OFF – Complications
- Critical Case Considerations
- Continuous Dopaminergic Stimulation – Dr. Stuart Isaacson
- Coming Up Next: Managing Motor Complications In Parkinson’s Disease
- Clinical Manifestations, Pathophysiology and Impact of Motor Fluctuations in Patients
- Clinical Data of Opicapone ▼ for the Management of Motor Fluctuations in PD Patients
- Charco Neurotech – CUE1: Prof. James Kilner
- Changing the paradigm for treating motor fluctuations in Parkinson’s: advancements in COMT inhibition
- Botulinum Neurotoxin And Dystonia: A Case For Greater Flexibility In Treatment Regimens?
- An update of opicapone in Parkinson’s disease: evidence-based results of recent trials
- An Introduction to the Pharmacokinetics of Levodopa – Prof. Fabrizio Stocchi
- Am Impakt: Apomorphine For Morning Akinesia Trial – Results
- A2A Receptor Antagonists: Potential adjuvant therapies for levodopa optimisation
- “I am Cheryl”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia
- “I am David”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia
- ‘Wearing off’ to L-DOPA and its underlying mechanisms
Multiple Sclerosis
- Working with Multiple Sclerosis
- Why some multiple sclerosis- patients stop disease modifying treatment in MS and why some don’t start at all
- What is MS?
- Vitamin D Levels Correspond to Disability in MS
- Treating Multiple Sclerosis with a Breakthrough Drug
- Time To First Relapse As An Endpoint In Multiple Sclerosis Clinical Trials
- THC Fails to Delay Progression of Multiple Sclerosis
- Study Finds Many Missed MS Diagnoses in Emergency Department
- Resilience – Addressing the Challenges of MS
- Rehabilitation In MS
- Parenting And MS
- New MS Criteria Aim to Simplify Diagnosis
- Multiple Sclerosis Does Not Hurt Pregnancy, Birth Outcomes
- MS-Optic Neuritis
- MS-Exercise
- MS & Recreation
- MS & Nutrition
- Ms & Nutrition
- Ms & Exercise
- Ms & Education – Optic Neuritis
- MS & Depression
- MS & Dating
- mRNA Vaccines & Their Potential In Multiple Sclerosis
- Managing Bladder & Bowel Issues In MS
- Manage Multiple Sclerosis Pain
- Low Incidence Of Venous Insufficiency In MS
- Laquinimod Halted MS Disability But Not Relapses
- Kids Get MS, too – National MS Society
- Is there A Multiple Sclerosis Epidemic And Is It The Result Of A Plethora Of Etiological Factors Or Of An As Yet Unknown Or Emergent Latent Risk Factor?
- Interferon-Beta Fails to Slow the Progression of Disability in MS
- Initiate Interferon Beta-1a Early to Delay Progression to MS
- IL-7 Level May Mark Interferon Responsiveness
- How Does Multiple Sclerosis Progress? Possible Clues Discovered
- Future MS Care: A consensus Statement Of The MS In The 21st Century Steering Group
- Fingolimod Label Advises ECG Monitoring at First Dose
- FDA Approves Oral MS Drug Teriflunomide
- European Multiple Sclerosis Platform November 2014 Newsletter
- European Multiple Sclerosis Platform January 2015 Newsletter
- EMSP’s MS Nurse Pro: Recognizing The Key Role Of MS Nurses
- Educating And Enhancing The Role Of Belgian MS Nurses
- Early symptoms of Multiple Sclerosis (MS)
- Drug For Alzheimer’s, Parkinson’s And MS Shows Promise
- COVID-19 and Multiple Sclerosis Update
- CombiRx For MS Not Better Than Monotherapy
- Cerebrospinal Fluid Prognostic Biomarkers In Multiple Sclerosis
- CarePartners And MS
- BG-12 Cuts Relapse Rate, Lesions in Multiple Sclerosis
- Balloon Angioplasty Improves Venous Flow in MS Patients
- Algorithm May Help Cut PML Risk With Natalizumab
- A Collaborative Initiative To Improve MS Research And Policy Across Europe
- 2014 Joint Actrims-Ectrims Meeting – EMSP Highlights Report
Neuro-Oncology
- What’s New in Neuro-Oncology at Massey (Insider’s Experience) – 2021 05 20
- What is neuro-oncology?
- Subspecialty Discussion: Neuro-Oncology
- Rare Brainstem Glioma Doesn’t Stop Former Marine
- PET/CT Pinpoints Physiological Evidence Of Chemo Brain
- PET Radiotracer Identifies Glioma Treatment Response
- Pediatric Neuro Oncology – by Dr Pankaj
- Neurosurgical Oncology
- Neuro-Oncology with Dr. Eric Burton
- Neuro-Oncology Conversations: Brain Tumor Symptoms
- Neuro-Oncology Conversations: Brain Tumor Clinical Trials
- Neuro Oncology Fellowships at Johns Hopkins All Children’s Hospital
- In the Pipeline: Immunotherapy Slows Childhood Gliomas
- Gamma Knife Surgery Cuts Seizures in Tumor Patients
- Early Surgery Yields Survival Benefit For Low-Grade Gliomas
- Duloxetine Eases Pain of Chemo-Induced Neuropathy
- CNS Events Not Immediately Fatal in Mantle Cell Lymphomas
- Chemotherapy-Induced Neuropathy Linked to Falls
- Can Lapatinib Prevent Brain Metastases From Breast Cancer? Data ‘Inconclusive’
- Brain Tumors Glow ‘Like Lava’ With New Surgical Probe
- Adjuvant PCV Chemo Hikes Oligodendroglioma Survival
- Acetyl-l-Carnitine Yields Mixed Results for Chemo-Induced Neuropathy
- ‘Scrambler’ Device Reduces Refractory Neuropathic Pain
Neurology
- X Surface Treatment: The Latest Advancement in Flow Diversion Technology
- World-Renowned Doctor Heads Neurosurgery Clinic At GEMC
- Working with Multiple Sclerosis
- Why some multiple sclerosis- patients stop disease modifying treatment in MS and why some don’t start at all
- What’s New In Parkinson’s Rating Scales?
- What’s the connection between sleep and Alzheimer’s disease? | Sleeping with Science
- What’s New in Neuro-Oncology at Massey (Insider’s Experience) – 2021 05 20
- What to do when the honeymoon wears off
- What Really Causes Epilepsy?
- What is the future for NOACs in secondary prevention of ESUS? – Christina Sjöstrand, Hans-Christoph Diener & George Ntaios
- What is neuro-oncology?
- What Is My Pd Journey?
- What is MS?
- What is Epilepsy?
- What is Epilepsy and How is it Treated?
- What does the new information on using epilepsy medication during pregnancy mean?
- What are Migraines?
- Welcome Message From The Co-Chairs Of The International Scientific And Organising Committee
- Weight Lifting Improves Physical Function in Parkinson’s
- Weighing Botox’s Migraine Benefits Against Costs
- WCNR2022: Experts discuss new findings on how to help the nervous system in the reorganisation process after irreversible damage
- Voice Disturbance Analysis Detects Parkinson’s
- Vitamin D Levels Correspond to Disability in MS
- Visual stress: origins and treatment
- Updates from Industry and New Technology Symposia, Friday 9th September, 2022 in Nice, France: 14th Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT)
- Uncontrolled Hypertension Could Bring Increased Risk For Alzheimer’s Disease
- Treatment Options For Atypical Parkin-Sonisms
- Treating Multiple Sclerosis with a Breakthrough Drug
- Treating motor fluctuations in Parkinson‘s Disease – Prof. Tobias Warnecke
- Treating Brain Tumors With Bacteria Gets Neuro-surgeons Banned
- Trauma-Induced Epilepsy May Be Prevented By Cooling The Brain Following Injury
- Transforming the stroke care continuum together
- Transforming stroke care continuum together. A symposium supported and organised by Medtronic, ESO-WSO Virtual Congress 2020
- Transcranial Neuro-stimulation Reduced Postop Pain, Opioid Use
- Topical Pain Relievers: FDA Issues Burn Warning
- Time To First Relapse As An Endpoint In Multiple Sclerosis Clinical Trials
- Thrombectomy technique choices
- Three Part Round Table Discussion: Which Techniques To Achieve FPE? Experts Share Their Daily Practice
- The Value of Neurosurgical APPs
- The role of on-demand medications in Parkinson’s Disease – Prof. Joaquim Ferreira, Prof. Angelo Antonini & Dr Susan Fox
- The Role Of Apomorphine In The Effective Management Of Parkinson’S Disease – Highlights From Cony 2014
- Protected: The Novel Oral Anticoagulants For Af…What Do The Sub-Analyses Tell Us?
- The Next Frontier for Parkinson’s disease and Movement Disorders: The Middle East, North Africa and South Asia (MENASA) region
- The Impact Of Thrombectomy For Stroke Patients In the UK – World Stroke Day 29th October 2022
- The impact of COVID-19 on Hemorrhagic Procedures
- The impact of COVID-19 for families with Parkinson’s Disease
- The honeymoon’s over: what next for people with Parkinson’s?
- The Future of Neurosurgery
- The Evolving Endovascular Therapy Toolkit: Real-World and Clinical Experiences with Pipeline Flex and Vantage with Shield Technology and Solitaire X 3 mm
- The efficacy of Apomorphine – A non-motor perspective: Prof. K Ray Chaudhuri
- The Diagnosis of Parkinson’s Disease – Dr. Francesca Morgante
- The Clinical Validation Of Objective Measurement Of Movement In Parkinson’s Disease
- The changing world of innovative stroke treatment
- The Angels Initiative: Stroke care taking flight with the wings of Angels – ESO-WSO Virtual Congress 2020
- The Angels Initiative at ESOC 2021
- The Angels (Acute-Networks StrivinG For ExceLlence In Stroke) Initiative: Solving A Problem By Giving Physicians The Tools They Need To Create A Solution
- THC Fails to Delay Progression of Multiple Sclerosis
- Tenecteplase Edges TPA in Acute Stroke
- Ten Warning Signs of Alzheimer’s Disease
- Ten Tips for Preventing Alzheimer’s Disease
- Technical Advances In Neurosurgery
- Tailoring Levodopa according to patient characteristics
- Tai Chi Improved Postural Stability in Parkinson’s Disease
- Symptom Triad May Identify Parkinson’s Risk
- Surgical Removal of Brain Thrombus Boosts Recovery
- Subspecialty Discussion: Neuro-Oncology
- Study Suggests New Potential Alzheimer’s Treatment Strategy
- Study Hints at Statins’ Protective Effect Against Parkinson’s
- Study Finds Many Missed MS Diagnoses in Emergency Department
- Study Finds Long-Term Benefits Of DBS In Refractory Epilepsy
- Studies Identify Early Changes In Familial Alzheimer’s Disease
- Studies Bolster Alzheimer’s Amyloid Hypothesis
- Strokes Mix Up Brain And Muscle Coordination
- Stroke Treatment From Onset To Rehabilitation
- Stroke Severity Is Key in Hospital Rankings for Stroke Outcomes
- Stroke Prevention in AF: Study Finds Some Differences Among New OACs
- Stroke care taking flight with the wings of ANGELS
- Stroke Association Reviewing Stroke Definition, New Anticoagulants
- Spinal Cord Stimulation an Option for Chronic Pain
- Some Recommendations To Address The Burden Of Stroke In Europe
- Solitaire Trumped Merci in Stroke Clot Retrieval Trial
- Solitaire Clot Remover Effective for Large Artery Stroke
- So You Want to Be a NEUROSURGEON?
- Sleep Problems May Increase Risk for Dementia
- Sleep and Epilepsy (Wellness Institute Whiteboard Video Series)
- Skin Cancer Drug Steps Into New Alzheimer’s Study
- Significant Risk Factors In The Etiology Of Arterial Ischemic Stroke In Children
- Selecting patients for endovascular therapy and recent developments and clinical experience with Medtronic devices
- Secondary Stroke Prevention: Who Can Benefit from Device Therapies?
- Secondary Headaches Flag Medical Conditions in Pregnancy
- Scores Help Identify Stroke Patients at Risk of Brain Bleed
- S2 EP7: ABC of PD – The Letter N (Part 2): Non Motor Symptoms – Apomorphine
- S2 EP6: ABC of PD – The Letter N: Non Motor Symptoms
- S2 EP5: ABC of PD – The Letter O: ON/OFF, On Demand Therapies, Opicapone
- Roundtable discussion, Professors Werner Poewe, Angelo Antonini and Oliver Rascol discuss: “Is Delaying Levodopa a Disservice to Patients?”
- Roundtable Discussion – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention
- Rotigotine Patch Has Favorable Results in Parkinson’s, Restless Legs
- Role, Function and Effect of Catechol-O-Methyl Transferase In Humans And Parkinson Disease
- Role of Patent Foramen Ovale Varies in Cryptogenic Strokes
- Roche AD Taxi: How can we support primary care physicians with an AD diagnosis? – Dr Diana Kerwin
- Roche AD Taxi: Biomarkers for the diagnosis of late-stage dementia: Are we there yet? – Dr Diana Kerwin
- Roche AD Taxi: Biomarkers and the AD continuum – Prof. Henrik Zetterberg
- Roche AD Taxi: An introduction to biomarkers in AD – Prof. Henrik Zetterberg
- Robots May Extend Post-Stroke Race
- Risk Factors Identified for Impulse Control Disorders in Parkinson’s
- Resilience – Addressing the Challenges of MS
- Rehabilitation In MS
- Reflections on Parkinson’s Disease Podcast – S2 EP4: ABC of PD – The Letter G: GBA and Genetics
- Reflections on Parkinson’s Disease Podcast – S2 EP3: ABC of PD – The Letter F: Fluctuations & Fatigue
- Reflections on Parkinson’s Disease Podcast – S2 EP2: ABC of PD – The Letter E: Early Morning Off, Evidence, Exercise, Early PD
- Reflections on Parkinson’s Disease Podcast – S2 EP1: ABC of PD – The Letter C: COMT Inhibitors, Continuous Dopaminergic Delivery
- Reflections on Parkinson’s Disease Podcast – EP7: Apomorphine and non-motor symptoms
- Reflections on Parkinson’s Disease Podcast – EP6: Talking PD – Issues in doctor-patient communication
- Reflections on Parkinson’s Disease Podcast – EP5: The Hardships Of Being Off
- Reflections on Parkinson’s Disease Podcast – EP4: Response Fluctuations in Parkinson’s Disease and why they can be missed
- Reflections on Parkinson’s Disease Podcast – EP3: Why PD patients start to fluctuate
- Reflections on Parkinson’s Disease Podcast – EP2: Motor Fluctuations and the levodopa long-duration response
- Reflections on Parkinson’s Disease Podcast – EP1: Levodopa Facts and Myths
- REDEFINING FLOW DIVERSION WITH PIPELINE™ FLEX WITH SHIELD™ TECHNOLOGY: RELEASE OF NEW CLINICAL DATA
- Recognition and Management of Wearing Off Utilisation of Catechol-O-Methyltransferase (COMT) Inhibitors – Olivier Rascol
- RE-SPECT ESUS: Optimizing Prevention of Embolic Stroke of Undetermined Source – Mike Sharma, Richard A. Bernstein & Hans-Christoph Diener
- RE-SPECT ESUS: Dabigatran versus acetylsalicylic acid for stroke prevention in patients with embolic stroke of undetermined source – Hans-Christoph Diener
- Re-Shaping the Future of Neurosurgery: A conversation with Dr. Gelareh Zadeh
- Rare Brainstem Glioma Doesn’t Stop Former Marine
- Psychosis in Alzheimer’s May Recur After Dropping Risperidone
- Progesterone Quells Some Intractable Catamenial Seizures
- Prof. Dr. István Szikora – Press conference in October on the national stroke imaging network
- Prof. David Devos, MD, PhD Expert opinion on early start of infusion therapies in PD (interview during MDS Congress, Nice, France, 24.09.2019)
- Prof. Angelo Antonini, MD, PhD – MDS Congress Madrid 2022
- Primary Care Docs Unsure When To Refer For Pediatric Epilepsy Surgery
- Pretreatment ASPECTS Reading Affects Stroke Outcomes
- Pregnancy, Contraception Data Highlighted in Epilepsy Registry
- Prediction Rule Targets Side Effects of Antiepileptic Drugs
- Plotting A Better Pathway For Parkinson’s Disease: The My PD Journey Project
- Pilot Program Shows Cardiac Rehab Can Help Poststroke
- Physiotherapy Found to Have Short-Term Benefit in Parkinson’s
- Pharmacodynamics of levodopa in the pathophysiology of fluctuations in Parkinson’s disease – Prof. Fabrizio Stocchi
- PET/CT Pinpoints Physiological Evidence Of Chemo Brain
- PET Radiotracer Identifies Glioma Treatment Response
- People over the world talk about their Parkinson’s – Chapter 1
- Pediatric Neuro Oncology – by Dr Pankaj
- Past And Future Of Stroke Care In Europe – How Can Sits Support?
- Past & Future Of Stroke Care In Europe
- Parkinson’s Life – A new ‘Webzine’ For The International Parkinson’s Community Now Live!
- Parkinson’s Life podcast: a voice for the global Parkinson’s community. LISTEN TO THE NEW EPISODE 5
- Parkinson’s Disease: An update on basic concepts – Dr Monica Kurtis
- Parkinson’s Disease – Patient Roleplay
- Parenting And MS
- Panel Votes Against Hydrocodone Because Of Abuse Potential
- Panel Discusses Direction of Alzheimer’s Disease Research
- Pain Scales: What to Ponder When Making Your Pick
- Overview Of Treatment In Infantile Spasms
- Oruen Testimonial by Professor Werner Poewe
- Oruen Testimonial by Dr. Monica Kurtis
- Oral Relaxin Improves Poststroke Recovery
- Optogenetic Manipulation Of The Cholinergic System: Potential Implications For The Treatment Of Memory Deficits In Alzheimer’s Disease
- Onset Periods of Depression Linked to Different Dementias
- Olfaction in migraine and its psychiatric comorbidities: a narrative review
- Ocular Tremor a Possible Biomarker for Early Parkinson’s Disease
- Occipital Nerve Block For Cluster Headache: Two Thumbs Up
- Novel Stroke Prophylaxis Strategies: When Should Device-Based Cardiac Occlusion Therapies Be Considered?
- Nonmotor Symptoms In Parkinson’s Disease Recognition & Management
- Nondrug Interventions Can Improve Dementia Patients’ Lives
- Nocturnal Sleep Boosts Working Memory Training in Parkinson’s
- Nociceptors – An Introduction to Pain
- NOACs in Secondary Stroke Prevention – Robin Lemmens, Ales Tomek & Milan R. Voško
- New Stroke Outcome Data – Prolonged Cardiac Monitoring Prevents Secondary Strokes – Valeria Caso, Helmut Pürerfellner & Georgios Tsivgoulis
- New Seizure Classifications Challenge Old Ideologies
- New MS Criteria Aim to Simplify Diagnosis
- New Drugs, Devices Edge Toward Clinical Use : New antiepileptic drugs in the pipeline may provide enhanced safety, tolerability, or potency.
- New Developments In Parkinson’s Disease Management: Interviews With The Experts
- New Developments In Parkinson’s Disease Management: Interviews With The Experts
- New Alzheimer Europe report identifies key recommendations on legal capacity and decision making of people with dementia
- Neurosurgical Oncology
- Neurosurgery: It’s the Journey, Not the Destination
- Neuroscience: Pain and the Anterolateral System
- Neuropsychological Data Endorse Preclinical Alzheimer’s
- Neuromelanin MR Imaging In Parkinson’s Disease
- NeuroBytes: Understanding the Experience of Pain: A Neuro-Palliative Approach
- Neuro-Oncology with Dr. Eric Burton
- Neuro-Oncology Conversations: Brain Tumor Symptoms
- Neuro-Oncology Conversations: Brain Tumor Clinical Trials
- Neuro Oncology Fellowships at Johns Hopkins All Children’s Hospital
- Nearly Half Have No Seizures at 10 Years Postop
- Natural Toxins: Their Roles In Developing PD
- National Plan Aims to Eliminate Alzheimer’s By 2025
- Multiple Sclerosis Does Not Hurt Pregnancy, Birth Outcomes
- Multidisciplinary care in PD – Does it make a difference?
- MS-Optic Neuritis
- MS-Exercise
- MS & Recreation
- MS & Nutrition
- Ms & Nutrition
- Ms & Exercise
- Ms & Education – Optic Neuritis
- MS & Depression
- MS & Dating
- mRNA Vaccines & Their Potential In Multiple Sclerosis
- Monitoring Antipsychotic Side Effects Infrequent Among Dementia Patients
- Modulation of Levodopa Metabolism, The Role of COMT Inhibition and Opicapone ▼ Pharmacologic Profile
- Minimizing The Risk Of Hemorrhagic Stroke During Oral Anticoagulant Therapy For Atrial Fibrillation: The Neurologist’s Perspective
- Minimizing The Risk Of Haemorrhagic Stroke During Oral Anticoagulant Therapy For Atrial Fibrillation: The Neurologists’ Perspectives
- Miniature Neuro-Stimulator Zaps Chronic Cluster Headache
- Migraines – Pathophysiology & Treatment (Described Concisely)
- Migraine With Aura: Aspirin Called Best Prophylaxis
- Migraine and Headache – Ask Dr. Ailani
- Migraine | Migraine Relief Treatment
- MicroVention-Terumo symposiums from ESMINT 2022, Nice, France
- Metformin Eyed for Lumbar Radiculopathy Pain
- Meta-Analysis: Statins Don’t Prevent Stroke, Death in Women
- Mental Training For Reinstallation Of Motor Programs After Stroke – Fiction Or Science?
- Memory Declines Years Before Stroke Strikes
- Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
- Medtronic – Webinar Session: AVM Treatment
- Medtronic – Webinar Session: Aneurysm Treatment – Flow Diversion Complex Cases
- Medtronic – The Importance of Thrombectomy
- Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (German)
- Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (English)
- Medtronic – Acute Ischemic Stroke Launch Symposium
- Medical Food, Supplement Appear Helpful for Dementias
- Mechanical Thrombectomy, The Change Is Coming.
- Mechanical Embolectomy Device Cleared for Acute Stroke Treatment
- Measurement And Improvement Of Stroke Care, Eso-East
- MCI in Parkinson’s Linked to Frontostriatal Dysfunction
- Maternal Hypertension Ups Infant’s Stroke Risk
- Managing Migraine Headaches
- Managing Bladder & Bowel Issues In MS
- Management of Parkinson’s Disease: From Science to Clinical Wisdom, Prof. Werner Poewe, Prof. Fabrizio Stocchi, Prof. Georg Ebersbach & Dr. Francesca Morgante
- Manage Multiple Sclerosis Pain
- Low Incidence Of Venous Insufficiency In MS
- Living with Alzheimer’s disease
- Life after stroke – what is the problem?
- Levodopa Mythology – Dr Alberto Espay
- Leaving A Legacy Of Stroke In Europe: A Community Of Dedicated Professionals Is Changing The Face Of Stroke In Europe
- Learnings from the ESUS trials – Jesse Dawson, Martin Grond & Maurizio Paciaroni
- Laquinimod Halted MS Disability But Not Relapses
- Kids Get MS, too – National MS Society
- Is there A Multiple Sclerosis Epidemic And Is It The Result Of A Plethora Of Etiological Factors Or Of An As Yet Unknown Or Emergent Latent Risk Factor?
- IOM Report on Epilepsy Supports Comprehensive Approach
- Involving PD patients in their treatment management: Expert discussion: Prof Bas Bloem & Dr Margherita Fabbri
- Introduction To The Symposium
- Interviewing a Professor of Neurosurgery – Dr Oren Gottfried MD
- Interview With WSO President: Prof. Michael Brainin
- Interview with the President of the ESMINT 2022 Annual Meeting – Dr Mohamed Aggour
- Interview With MDS President: Prof. Claudia Trenkwalder
- Interview with EMSP President: Prof. Pedro Carrascal
- Interferon-Beta Fails to Slow the Progression of Disability in MS
- Innovations Driven By Clinical Evidence
- Initiate Interferon Beta-1a Early to Delay Progression to MS
- Infection Correlated With Stroke Risk in Children
- In-Hospital Management Of Acute Ischaemic Stroke: How Can We Do Better?
- In the Pipeline: Immunotherapy Slows Childhood Gliomas
- Implementation of Best Practice in Europe: The Angels Initiative – The Role Of ESO
- Implanted EEG Device Predicts Seizures in Early Study
- IL-7 Level May Mark Interferon Responsiveness
- Ideas and Innovations in Acute Ischaemic Stroke Treatment
- How Does Multiple Sclerosis Progress? Possible Clues Discovered
- How Do You Become a Neurosurgeon?
- Hormonal Contraception Raises Thrombotic Stroke, MI Risk
- High-Tech Stroke Recovery Aids? More Likely Than You May Think
- High-Risk Alzheimer’s Gene Increases Risk Of Other Dementias
- Help Make Real Change Happen For People Living With Dementia – Sign The Glasgow Declaration!
- Greater Costs, Morbidity Among Uncontrolled Epilepsy Patients
- Glutamate From Gliomas Sparks Seizures
- Get Rid of Migraines Naturally and Fast!
- Genome Sequencing Set to Hunt for Alzheimer’s Clues
- Gamma Knife Surgery Cuts Seizures in Tumor Patients
- Gamma Knife Surgery Cuts Seizures in Tumor Patients
- Future MS Care: A consensus Statement Of The MS In The 21st Century Steering Group
- Frovatriptan Shown Advantageous In Menstrual Migraine
- Protected: From Studies To Real-Life Evidence…Latest Insights From The Garfield Af Registry
- Framingham Score Flags MI Risk After Stroke
- Fingolimod Label Advises ECG Monitoring at First Dose
- Filgrastim Fails to Improve Ischemic Stroke Outcomes
- Federal Funds Launch First Alzheimer’s Prevention Study
- FEBSTAT Study Hints At Predictors Of Epilepsy
- FDA Approves Oral MS Drug Teriflunomide
- Family History Tops Parkinson’s Disease Risk Factors
- Experimental Drug Improves Cognition, Memory in Alzheimer’s
- Exercise May Be The Best Medicine For Alzheimer’s
- Exercise Improved Some Cognitive Function in Parkinson’s
- Exclusive Interview With ESO President: Prof. Martin Dichgans
- European Multiple Sclerosis Platform November 2014 Newsletter
- European Multiple Sclerosis Platform January 2015 Newsletter
- Establishing stroke systems of care from the bottom to the top: A global perspective
- ESOC 2021: Shaping the future
- ESOC 2019 – MEDTRONIC CARE CONTINUUM: Improving Patient Pathway
- ESOC 2017 Conference News
- ESOC 2017 – Day 2 Highlights
- ESOC 2017 – Day 1 Highlights
- ESO Endorsed Medtronic Webinar: Cryptogenic Stroke Patients Need Answers: AF Screening Strategies & Patient Stratification
- ESO Endorsed Medtronic Webinar: AF screening in Cryptogenic Stroke patients, from guidelines to daily practice – 26th January 2023
- ESO And SAFE Kick-Off The Implementation Of The Stroke Action Plan For Europe (SAP-E) – A Major Initiative To Reduce The Burden Of Stroke In Europe
- ESO & S.A.F.E – Declaration for Action on Stroke launches on European Stroke Awareness Day
- ESO / SAFE Press Release: Ukraine signs the Stroke Action Plan for Europe Declaration
- ESMINT PRESS RELEASE: Prof Dr Christian Taschner appointed to the European Commission’s Medical Devices Expert Panel
- ESC 2014. In-Hospital Management Of Acute Ischaemic Stroke: How Can We Do Better?
- Epilepsy research: MRI | NHS
- Epilepsy Raises Risk For Sudden Cardiac Arrest
- Epilepsy Incidence High Following Pediatric Stroke
- Epilepsy Incidence High Following Pediatric Stroke
- Epilepsy and Mental Health: What You Should Know
- EPDA #UniteForParkinsons
- Environment Modifies ApoE e4-Related Risk of Alzheimer’s Disease
- EMSP’s MS Nurse Pro: Recognizing The Key Role Of MS Nurses
- Embolic Stroke of Undetermined Source (ESUS) – Valeria Caso, Danilo Toni & Martin Grond
- Elderly Stroke Patients Have High Atrial Fibrillation Prevalence
- Effect of vibrotactile stimulation with cueing on falls in Parkinson’s disease: case study
- Educating And Enhancing The Role Of Belgian MS Nurses
- Early vs Late Use Of Levodopa – Angelo Antonini
- Early use of Levodopa vs Levodopa-sparing strategies
- Early symptoms of Multiple Sclerosis (MS)
- Early Surgery Yields Survival Benefit For Low-Grade Gliomas
- Early Surgery Deemed Best for Drug-Resistant Epilepsy
- Early Surgery Deemed Best for Drug-Resistant Epilepsy
- EANS2022 Abstract Submission is now open!
- EANS activities, busy as ever!
- EANS 2022 Belgrade Congress: An event to remember!
- EANS 2020: The 20th European Congress of Neurosurgery goes virtual – Register Here!
- Dysfunctional Brain Areas May Fuel Inattention in Absence Epilepsy
- During greatest public health crisis in living memory, European Commission adopts first Work Plan of new EU4Health Programme undermining key activities of European health NGOs
- Duloxetine Eases Pain of Chemo-Induced Neuropathy
- Drugs Found To Both Prevent And Treat Alzheimer’s Disease In Mice
- Drug For Alzheimer’s, Parkinson’s And MS Shows Promise
- Drug Dosage, Gender Affect Impulsivity Prognosis in Parkinson’s
- Dr Don Frei shares insights about REDglide Difference & discusses ADAPT Technology with Joan Kristensen
- Disparities Seen in Care of Parkinson’s Patients : Better clinical care associated with neurologists was often unavailable to women or minorities.
- Diagnosis and Management of Wearing Off – Repositioning COMTi and Response Duration in Levodopa Optimisation
- Diagnosis and Management of Levodopa Response Fluctuations in Parkinson’s Disease
- Diagnosis and Management of Headache
- Despite Potential Gains, Patients Balk at Epilepsy Surgery
- Depressed Stroke Survivors At Increased Risk Of Death
- Delirium Hits Hard in Hospitalized Alzheimer’s Patients
- Delayed ON And Wearing OFF – Complications
- CT Perfusion in Acute Stroke Questioned
- Cryptogenic Stroke Webinar – ESO-WSO Virtual Congress 2020
- Critical Case Considerations
- COVID-19 and Multiple Sclerosis Update
- Continuous Dopaminergic Stimulation – Dr. Stuart Isaacson
- Continuing Donepezil Appears Best for Some Alzheimer’s Patients
- Coming Up Next: Managing Motor Complications In Parkinson’s Disease
- CombiRx For MS Not Better Than Monotherapy
- Coffee Consumption Linked to Lower Dementia Risk in Elderly
- CNS Events Not Immediately Fatal in Mantle Cell Lymphomas
- Clot-Busters Safely Treated Wake-Up Stroke Patients
- Clinical, Social Barriers Cripple Adequate Alzheimer’s Care
- Clinical Manifestations, Pathophysiology and Impact of Motor Fluctuations in Patients
- Clinical Data of Opicapone ▼ for the Management of Motor Fluctuations in PD Patients
- Chronic Musculo-Skeletal Pain Travels With Chronic Daily Headache
- Chronic Migraine Linked to More Stressful Life Events
- Chemotherapy-Induced Neuropathy Linked to Falls
- Charco Neurotech – CUE1: Prof. James Kilner
- Changing the paradigm for treating motor fluctuations in Parkinson’s: advancements in COMT inhibition
- Changing How We Prescribe Antipsychotics for Dementia
- Cerebrospinal Fluid Prognostic Biomarkers In Multiple Sclerosis
- Cavernous Malformation Of Left Basal Ganglia Region In A 12-Year-Old Boy – Case Report.
- CarePartners And MS
- Can Lapatinib Prevent Brain Metastases From Breast Cancer? Data ‘Inconclusive’
- Buphenyl Identified As A Possible Drug For Alzheimer’s Disease
- Brain Tumors Glow ‘Like Lava’ With New Surgical Probe
- Botulinum Neurotoxin And Dystonia: A Case For Greater Flexibility In Treatment Regimens?
- Botox May Greatly Reduce Migraine Chronicity
- Botox For Chronic Migraine Brings Cost Savings
- Boehringer Ingelheim: WSC 2018 – secondary stroke prevention: new evidence that demands a verdict
- Boehringer Ingelheim: ESOC 2019 – How NOAC selection and reversal can help protect our patients: Your questions answered
- Boehringer Ingelheim: Angels WSC 2018 – Improving Stroke Care Across The World: The Angels Initiative
- Boehringer Ingelheim: Angels ESOC 2019 – THE ANGELS INITIATIVE: 3 YEARS AND COUNTING
- Boehringer Ingelheim: Actilyse WSC 2018 – New Frontiers in Acute Ischaemic Stroke Reperfusion
- Boehringer Ingelheim ESOC 2018 – Stroke Prevention and Treatment: New Insights Into NOACS and Reversal
- Blood Test May Predict Alzheimer’s in Cognitively Impaired
- Biomarkers May Aid Differential Diagnosis of Dementias, Parkinsonism
- BG-12 Cuts Relapse Rate, Lesions in Multiple Sclerosis
- Benefit of IVIG in Alzheimer’s Disease Appears Durable
- Bayer: ESOC 2019 – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention
- Balloon Angioplasty Improves Venous Flow in MS Patients
- Avatar image Ageing and Alzheimer’s disease: the search for the cure
- Atrial Fibrailation In Young Stroke Patients
- Anticoagulation for Cerebral Venous Thrombosis
- Antibody Reduces Amyloid-Beta in Alzheimer’s
- Protected: Anti-Coagulation With Novel Oac’s In Af, Practical Guidance And Interactive Session
- Angels: FAST Heroes: Results of cross-country implementation of a global school-based stroke education campaign – ESOC 2022 Studios
- Angels ESOC 2018 – Experience From Today For The Stroke Care Of The Future
- Anemia Triples Post-Stroke Mortality Risk
- An update on innovative stroke treatment
- An update of opicapone in Parkinson’s disease: evidence-based results of recent trials
- An Introduction to the Pharmacokinetics of Levodopa – Prof. Fabrizio Stocchi
- An insight into the upcoming ESMINT Annual Meeting – Nice, France 2022
- An alternative treatment to prevent stroke in patients with Atrial Fibrillation: Left Atrial Appendage Occlusion-Latest evidence
- Amyloid Imaging Agent May Aid Alzheimer’s Diagnosis
- Am Impakt: Apomorphine For Morning Akinesia Trial – Results
- Alzheimer’s Disease: What You Need to Know – The #COVID19 Edition
- Alzheimer’s Imaging Agent Considered For Medicare Coverage
- Alzheimer’s Drug Misses Primary End Points in Trials
- Alzheimer Europe sets out recommendations to improve data sharing in dementia research
- Alzheimer Europe publishes two new reports: One on sex, gender and sexuality in the context of dementia, and one on dementia-inclusive initiatives and communities
- Alzheimer Europe position regarding the prioritisation of people with dementia for COVID-19 vaccination
- Alzheimer Europe hosts European Parliament Lunch Debate examining EU and WHO policies on neurological conditions
- Alzheimer Europe 2020 Conference, Opening & Roundtable discussion: Dementia in a changing world
- Alzheimer Europe 2020 Conference Round table discussion: Maintaining dementia as a European priority
- Alzheimer Europe 2020 Conference – Special symposium – My second new life: adapting after COVID-19
- Alzheimer disease – an Osmosis Preview
- All Acute Antimigraine Drugs Protect Against Chronic Migraine
- Alive or Dead? Secondary Stroke Prevention with NOACs in ESUS – Ken Butcher
- Algorithm May Help Cut PML Risk With Natalizumab
- Air Pollution May Hurt Cognition, Increase Strokes
- Ahead Of The Journals: Discontinuing Risperidone In AD
- Advanced Imaging To Extend The Therapeutic Time Window Of Acute Ischemic Stroke
- Adjuvant PCV Chemo Hikes Oligodendroglioma Survival
- Acetyl-l-Carnitine Yields Mixed Results for Chemo-Induced Neuropathy
- A2A Receptor Antagonists: Potential adjuvant therapies for levodopa optimisation
- A very warm welcome to our new advisory board member – Wolfgang Reith
- A testimonial from the ESO past president – Valeria Caso
- A Second Amyloid Could Play A Role In Alzheimer’s Disease
- A message from the ESO President – Professor Valeria Caso
- A Collaborative Initiative To Improve MS Research And Policy Across Europe
- 2014 Joint Actrims-Ectrims Meeting – EMSP Highlights Report
- 17-19 October: 32nd Alzheimer Europe Conference takes place in Bucharest and online under the banner “Building bridges”, bringing together 544 participants from 42 countries
- 1-2-1 interviews on WEB Study – Dr. Szikora, Dr. Arthur, Prof. Pierot & Propriety X Surface Treatment for Flow Diverter -Dr. Dion
- “Resilience in dementia: Moving beyond the COVID-19 pandemic” brings together over 600 participants from 38 countries
- “I am Cheryl”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia
- “I am David”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia
- ‘Wearing off’ to L-DOPA and its underlying mechanisms
- ‘Scrambler’ Device Reduces Refractory Neuropathic Pain
- ‘Drip and Ship’ Proves Safe for Stroke
Neurology Multimedia
Neurology TV
Neurology>All Articles For Neurology
Neurology>All Articles For Neurology|Latest News
Neurology>All Videos For Neurology|Home video|Neurology>Movement Disorders
- The Next Frontier for Parkinson’s disease and Movement Disorders: The Middle East, North Africa and South Asia (MENASA) region
- Parkinson’s Disease – Patient Roleplay
- Need of 2nd Line Therapies in Advanced Parkinson’s Disease – Remote Interview with Dr Ángel Sesar-Ignacio
- Multidisciplinary care in PD – Does it make a difference?
Neurology>All Videos For Neurology|Home video|Neurology>Movement Disorders|Parkinson's
Neurology>All Videos For Neurology|Home video|Neurology>Neuroradiology|Neurology>Stroke
Neurology>All Videos For Neurology|Home video|Neurology>Stroke
Neurology>All Videos For Neurology|Home video|Neurology>Stroke|Uncategorized
Neuroradiology
- X Surface Treatment: The Latest Advancement in Flow Diversion Technology
- Updates from Industry and New Technology Symposia, Friday 9th September, 2022 in Nice, France: 14th Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT)
- Transforming the stroke care continuum together
- Transforming stroke care continuum together. A symposium supported and organised by Medtronic, ESO-WSO Virtual Congress 2020
- Thrombectomy technique choices
- Three Part Round Table Discussion: Which Techniques To Achieve FPE? Experts Share Their Daily Practice
- The impact of COVID-19 on Hemorrhagic Procedures
- The Evolving Endovascular Therapy Toolkit: Real-World and Clinical Experiences with Pipeline Flex and Vantage with Shield Technology and Solitaire X 3 mm
- The changing world of innovative stroke treatment
- Selecting patients for endovascular therapy and recent developments and clinical experience with Medtronic devices
- REDEFINING FLOW DIVERSION WITH PIPELINE™ FLEX WITH SHIELD™ TECHNOLOGY: RELEASE OF NEW CLINICAL DATA
- Prof. Dr. István Szikora – Press conference in October on the national stroke imaging network
- MicroVention-Terumo symposiums from ESMINT 2022, Nice, France
- Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
- Medtronic – Webinar Session: AVM Treatment
- Medtronic – Webinar Session: Aneurysm Treatment – Flow Diversion Complex Cases
- Medtronic – The Importance of Thrombectomy
- Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (German)
- Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (English)
- Medtronic – Acute Ischemic Stroke Launch Symposium
- Interview with the President of the ESMINT 2022 Annual Meeting – Dr Mohamed Aggour
- Innovations Driven By Clinical Evidence
- Ideas and Innovations in Acute Ischaemic Stroke Treatment
- ESOC 2019 – MEDTRONIC CARE CONTINUUM: Improving Patient Pathway
- ESO Endorsed Medtronic Webinar: AF screening in Cryptogenic Stroke patients, from guidelines to daily practice – 26th January 2023
- ESMINT PRESS RELEASE: Prof Dr Christian Taschner appointed to the European Commission’s Medical Devices Expert Panel
- Dr Don Frei shares insights about REDglide Difference & discusses ADAPT Technology with Joan Kristensen
- An update on innovative stroke treatment
- An insight into the upcoming ESMINT Annual Meeting – Nice, France 2022
- 1-2-1 interviews on WEB Study – Dr. Szikora, Dr. Arthur, Prof. Pierot & Propriety X Surface Treatment for Flow Diverter -Dr. Dion
Neurosurgery
- World-Renowned Doctor Heads Neurosurgery Clinic At GEMC
- Treating Brain Tumors With Bacteria Gets Neuro-surgeons Banned
- The Value of Neurosurgical APPs
- The Future of Neurosurgery
- Technical Advances In Neurosurgery
- Surgical Removal of Brain Thrombus Boosts Recovery
- So You Want to Be a NEUROSURGEON?
- Re-Shaping the Future of Neurosurgery: A conversation with Dr. Gelareh Zadeh
- Neurosurgery: It’s the Journey, Not the Destination
- Interviewing a Professor of Neurosurgery – Dr Oren Gottfried MD
- How Do You Become a Neurosurgeon?
- ESMINT PRESS RELEASE: Prof Dr Christian Taschner appointed to the European Commission’s Medical Devices Expert Panel
- Early Surgery Deemed Best for Drug-Resistant Epilepsy
- EANS2022 Abstract Submission is now open!
- EANS activities, busy as ever!
- EANS 2022 Belgrade Congress: An event to remember!
- Despite Potential Gains, Patients Balk at Epilepsy Surgery
- Cavernous Malformation Of Left Basal Ganglia Region In A 12-Year-Old Boy – Case Report.
Obesity
OCD
- The International Society Of Affective Disorders
- OCD Commonly Precedes Schizophrenia in Men With Both
- Neurobiology of Obsessive Compulsive Disorder Simplified?
- Neurobiology of Obsessive Compulsive Disorder and Co Occurring Mental Health Issues
- Hoarding Not Related To OCD, New Findings Reveal
- Family-Focused Therapy May Help Resistant Pediatric OCD
- Brain and Behavior Based Strategies in the Treatment of OCD
Pain
- Transcranial Neuro-stimulation Reduced Postop Pain, Opioid Use
- Topical Pain Relievers: FDA Issues Burn Warning
- Spinal Cord Stimulation an Option for Chronic Pain
- Panel Votes Against Hydrocodone Because Of Abuse Potential
- Pain Scales: What to Ponder When Making Your Pick
- Nociceptors – An Introduction to Pain
- Neuroscience: Pain and the Anterolateral System
- NeuroBytes: Understanding the Experience of Pain: A Neuro-Palliative Approach
- Metformin Eyed for Lumbar Radiculopathy Pain
- Chronic Musculo-Skeletal Pain Travels With Chronic Daily Headache
Parkinson's
Podcasts
- S2 EP7: ABC of PD – The Letter N (Part 2): Non Motor Symptoms – Apomorphine
- S2 EP6: ABC of PD – The Letter N: Non Motor Symptoms
- S2 EP5: ABC of PD – The Letter O: ON/OFF, On Demand Therapies, Opicapone
- Reflections on Parkinson’s Disease Podcast – S2 EP4: ABC of PD – The Letter G: GBA and Genetics
- Reflections on Parkinson’s Disease Podcast – S2 EP3: ABC of PD – The Letter F: Fluctuations & Fatigue
- Reflections on Parkinson’s Disease Podcast – S2 EP2: ABC of PD – The Letter E: Early Morning Off, Evidence, Exercise, Early PD
- Reflections on Parkinson’s Disease Podcast – S2 EP1: ABC of PD – The Letter C: COMT Inhibitors, Continuous Dopaminergic Delivery
- Reflections on Parkinson’s Disease Podcast – EP7: Apomorphine and non-motor symptoms
- Reflections on Parkinson’s Disease Podcast – EP6: Talking PD – Issues in doctor-patient communication
- Reflections on Parkinson’s Disease Podcast – EP5: The Hardships Of Being Off
- Reflections on Parkinson’s Disease Podcast – EP4: Response Fluctuations in Parkinson’s Disease and why they can be missed
- Reflections on Parkinson’s Disease Podcast – EP3: Why PD patients start to fluctuate
- Reflections on Parkinson’s Disease Podcast – EP2: Motor Fluctuations and the levodopa long-duration response
- Reflections on Parkinson’s Disease Podcast – EP1: Levodopa Facts and Myths
Psychiatry
- Zolpidem Linked To Higher Inpatient Fall Rates
- What’s the connection between sleep and Alzheimer’s disease? | Sleeping with Science
- What is ADHD?
- We are pleased to announce our most recent media partnership with ESMINT
- Watch for Heavy Smoking in Schizophrenia
- Using SSRIS In Pregnancy
- Understanding the scattered (ADHD) brain
- Treating Childhood Sleep Apnea Improved Cognitive Function
- Treating Childhood Sleep Apnea Improved Cognitive Function
- Treat Comorbid Depression in Breast Cancer Patients
- Tobacco, Drug Use High Early in Course of Schizophrenia
- Tobacco, Drug Use High Early in Course of Schizophrenia
- Titrate ADHD Meds Quickly for Best Outcome
- The Science of Anxiety
- The Science of Addiction and The Brain
- The Papez circuit in schizophrenia 1: Neuropathological changes
- The Neuroscience of Addiction
- The International Society Of Affective Disorders
- The Brain’s Hunger/Satiety Pathways and Obesity
- The Brain Circuitry of Bipolar Disorder: A View from Brain Scanning Research
- The 4 Schizophrenia Symptoms You Need to Know
- Support for Parents Curbs Drug Use in Kids
- Suicidality Tied to ‘Self-Disorders’ in Early Schizophrenia
- Substance Abuse ‘Under-appreciated’ Among Elderly Psychiatric Inpatients
- Study Identifies Predictors Of Cognitive Impairment In Schizophrenia
- SSRI Antidepressants Safe For Depressed Epilepsy Patients
- Sleep-Disordered Breathing in Early Childhood Linked With Behavioral Outcomes
- Sleep Problems May Increase Risk for Dementia
- Sleep and Epilepsy (Wellness Institute Whiteboard Video Series)
- Skimping on Sleep May Increase Stroke Risk
- School Staff Can Aid Treatment of Psychotic Children
- Schizophrenia With Panic Disorder May Be a Distinct Subtype
- Schizophrenia Symptoms Linked To Faulty ‘Switch’ In Brain
- Schizophrenia Symptoms
- Schizophrenia – causes, symptoms, diagnosis, treatment & pathology
- Rewiring the Anxious Brain – Neuroplasticity and the Anxiety Cycle
- Range of Childhood Trauma Linked to Schizophrenia Risk
- Raloxifene Gains Ground as Adjunctive Schizophrenia Treatment
- RAISE: Early Intervention In Schizophrenia Put To The Test
- Psychosis Symptoms Tied To Higher Suicide Risk In Adolescents
- Phyto-Anxiolytic Effects Of A Fixed Herbal Drug Combination For The Relief Of Stress And Its Potential To Reduce Benzodiazepine Use
- Physical Symptoms of Depression
- Phone Therapy for Depression Boosts Treatment Adherence
- Persistent Daytime Sleepiness Common Despite Effective CPAP
- Patients At Risk For Psychosis Show Gradual Decrease In Hippocampal Volume
- Pathological changes in the Salience Network in schizophrenia.
- Panel Votes Against Hydrocodone Because Of Abuse Potential
- Oppositional Defiant Disorder Linked to Symptoms of Schizophrenia Spectrum Disorder
- Onset Periods of Depression Linked to Different Dementias
- Olfaction in migraine and its psychiatric comorbidities: a narrative review
- Older Adults With Schizophrenia Can Achieve Remission
- OCD Commonly Precedes Schizophrenia in Men With Both
- Obstructive sleep apnea, oxidative stress and endotelial dysfunction
- Obesity’s Impact on Brain Health
- Obesity Could Be Treated With Deep Brain Stimulation
- Obesity and diabetes linked to cognitive decline
- Novel Antipsychotic Treats Acute Mania in Bipolar Disorder
- Neuroscience of Anxiety
- Neuroscience – Addiction and the Brain
- Neuropath-Ological Changes In The Nucleus Basalis In Schizophrenia
- Neuroinflammation in Psychosis
- Neurochemical Traffic Signals May Open New Avenues For The Treatment Of Schizophrenia
- Neurobiology of Obsessive Compulsive Disorder Simplified?
- Neurobiology of Obsessive Compulsive Disorder and Co Occurring Mental Health Issues
- Neurobiology of Major Depressive Disorder and Bipolar Disorder
- My Experience with Schizophrenia/Schizoaffective Disorder
- More Evidence Confirms Relevance of Risk Allele to Schizophrenia
- Migraine With Aura: Aspirin Called Best Prophylaxis
- Metformin Resolves Amenorrhea in Antipsychotic-Treated Schizophrenia
- Melatonin May Normalize Night Owl Sleep Schedules
- Medical Comorbidity Affects Disease Course in Bipolar Disorder
- Marijuana Use Linked To Better Adherence In Psychosis
- Marijuana Use Linked To Better Adherence In Psychosis
- Mania With Depressive Symptoms: A Pathophysio-Logical Review
- Liquid, Extended-Release Drug Approved For ADHD
- Lifetime Estrogen Exposure Linked to Depression Risk in Perimenopause
- Levomilnacipran SR Effective for Major Depressive Disorder
- Is My Child ‘Bipolar’?
- Is ADHD An Advantage?
- Intranasal Oxytocin May Ease Schizophrenia Symptoms
- Interview with ECNP President: Prof. Gitte Moos Knudsen
- Intervention For Epilepsy Patients Helped Prevent Depression
- Insomnia, Hypersomnia Disorders Criteria Proposed for DSM-5
- Insomnia, Hypersomnia Disorders Criteria Proposed for DSM-5
- Insomnia Drug Helps Patients Sleep Sooner, Longer
- Include ‘Legal Highs,’ Designer Drugs in Screening
- ICD Shocks Boost Anxiety And Mortality
- How to Help Someone Who’s Lonely, Isolated, or Depressed
- Hot Topics in Obstructive Sleep Apnea – A European View
- Home Sleep Apnea Testing: Wake Up Call for Sleep Docs
- Hoarding Not Related To OCD, New Findings Reveal
- Genetic Discoveries May Help Kids With ADHD, Expert Says
- From Neuroscience to Novel Treatments for Psychosis
- Findings Boost Causal Argument for Smoking, Depression
- FDA Approves Low-Dose Zolpidem for Night Awakening
- FDA Approves First Generic Form of Escitalopram
- Family-Focused Therapy May Help Resistant Pediatric OCD
- Exercise Rivals Sertraline in Comorbid CHD, Depression
- ESRS Sleep Medicine Textbook
- ESRS Celebrates certification of more than 1100 Somnologists and Somnologist Technologists
- Epilepsy and Mental Health: What You Should Know
- Early Intervention May Help Keep Psychosis At Bay
- DSM-5 Cleared For Takeoff
- Don’t Overreach For Subthreshold Pediatric Bipolar Disorder
- Depression, Obesity Linked in Older Women but Not Older Men
- Depression vs Low Grade Depression: The Differences You Should Know
- Depression May Shorten Survival in Kidney Cancer
- Depression Linked to Unhealthy Dieting Among Women
- Depression Can Be Migraine’s Tipping Point
- Depression and Sleep
- Depressed RA Patients More Likely To Die, Especially Men
- Depot Injection Boosts Antipsychotic Compliance in Schizophrenia
- Current Digital Applications in Psychiatry, Specifically ADHD
- CPAP Improves Mood in Sleep Apnea Patients
- Contemporary Perspectives On Lacanian Theories Of Psychosis
- Computer Training Leads to Lasting Improvements in Schizophrenia
- Combine Sources of Information for Schizophrenia Symptom Assessment
- Combination Therapy Yields Mixed Results for PTSD, Substance Abuse
- Cognitive-Behavioral Therapy Dropped Suicidal Ideation Rate
- Cognitive Therapy Plus Active Monitoring Benefits People at Risk of Psychosis
- CDC Reports Autism Prevalence Continues to Rise
- Cancer More Common in People With Sleep Apnea
- C9orf72-Associated Frontotemporal Dementia And Psychosis
- Brief Introduction to Psychosis
- Brain and Behavior Based Strategies in the Treatment of OCD
- Bipolar disorder (depression & mania) – causes, symptoms, treatment & pathology
- Behavior Changes During Depression
- Attention Retraining Enhances CBT For Adolescent Anxiety
- Are Schizophrenia Simulations Accurate?
- Appetite, Obesity, and the Brain
- An Introduction To The Substantia Nigra In Schizophrenia
- An Introduction To The Putamen In Schizophrenia
- An Introduction To The Nucleus Accumbens In Schizophrenia
- An Introduction To The Caudate In Schizophrenia
- All Acute Antimigraine Drugs Protect Against Chronic Migraine
- Adjunctive Lithium Reduces Use of Newer Antipsychotics in Bipolar
- ADHD in Adulthood: The Signs You Need to Know
- Addiction Neuroscience 101
- A very warm welcome to our new advisory board member – Krassen Nedeltchev
- ‘On-Off’ Switches Shed Light on Brain Disorders : Narcolepsy, cataplexy, and REM sleep behavior disorder linked to errant ‘flip-flop’ mechanisms.
- ‘Mind-Pops’ More Common in Schizophrenia
Psychiatry Radio
Psychiatry TV
- Treating Childhood Sleep Apnea Improved Cognitive Function
- Studies Bolster Alzheimer’s Amyloid Hypothesis
- Sleep Problems May Increase Risk for Dementia
- Pediatric Psychiatry Services Infiltrate Primary Care
- Panel Discusses Direction of Alzheimer’s Disease Research
- Depressed RA Patients More Likely To Die, Especially Men
- Clues For Identifying Young People With Possible Psychosis
- Cancer More Common in People With Sleep Apnea
Psychosis
- The International Society Of Affective Disorders
- School Staff Can Aid Treatment of Psychotic Children
- Patients At Risk For Psychosis Show Gradual Decrease In Hippocampal Volume
- Neuroinflammation in Psychosis
- Marijuana Use Linked To Better Adherence In Psychosis
- From Neuroscience to Novel Treatments for Psychosis
- Contemporary Perspectives On Lacanian Theories Of Psychosis
- Cognitive Therapy Plus Active Monitoring Benefits People at Risk of Psychosis
- C9orf72-Associated Frontotemporal Dementia And Psychosis
- Brief Introduction to Psychosis
Reflections in parkinsons
- S2 EP7: ABC of PD – The Letter N (Part 2): Non Motor Symptoms – Apomorphine
- S2 EP6: ABC of PD – The Letter N: Non Motor Symptoms
- S2 EP5: ABC of PD – The Letter O: ON/OFF, On Demand Therapies, Opicapone
- Reflections on Parkinson’s Disease Podcast – S2 EP4: ABC of PD – The Letter G: GBA and Genetics
- Reflections on Parkinson’s Disease Podcast – S2 EP2: ABC of PD – The Letter E: Early Morning Off, Evidence, Exercise, Early PD
- Reflections on Parkinson’s Disease Podcast – S2 EP1: ABC of PD – The Letter C: COMT Inhibitors, Continuous Dopaminergic Delivery
- Reflections on Parkinson’s Disease Podcast – EP7: Apomorphine and non-motor symptoms
- Reflections on Parkinson’s Disease Podcast – EP6: Talking PD – Issues in doctor-patient communication
- Reflections on Parkinson’s Disease Podcast – EP5: The Hardships Of Being Off
- Reflections on Parkinson’s Disease Podcast – EP4: Response Fluctuations in Parkinson’s Disease and why they can be missed
- Reflections on Parkinson’s Disease Podcast – EP3: Why PD patients start to fluctuate
- Reflections on Parkinson’s Disease Podcast – EP2: Motor Fluctuations and the levodopa long-duration response
- Reflections on Parkinson’s Disease Podcast – EP1: Levodopa Facts and Myths
Research
Schizophrenia
- Watch for Heavy Smoking in Schizophrenia
- Tobacco, Drug Use High Early in Course of Schizophrenia
- The Papez circuit in schizophrenia 1: Neuropathological changes
- The International Society Of Affective Disorders
- The 4 Schizophrenia Symptoms You Need to Know
- Suicidality Tied to ‘Self-Disorders’ in Early Schizophrenia
- Study Identifies Predictors Of Cognitive Impairment In Schizophrenia
- Schizophrenia With Panic Disorder May Be a Distinct Subtype
- Schizophrenia Symptoms Linked To Faulty ‘Switch’ In Brain
- Schizophrenia Symptoms
- Schizophrenia – causes, symptoms, diagnosis, treatment & pathology
- Range of Childhood Trauma Linked to Schizophrenia Risk
- Raloxifene Gains Ground as Adjunctive Schizophrenia Treatment
- RAISE: Early Intervention In Schizophrenia Put To The Test
- Pathological changes in the Salience Network in schizophrenia.
- Oppositional Defiant Disorder Linked to Symptoms of Schizophrenia Spectrum Disorder
- Older Adults With Schizophrenia Can Achieve Remission
- OCD Commonly Precedes Schizophrenia in Men With Both
- Neuropath-Ological Changes In The Nucleus Basalis In Schizophrenia
- Neurochemical Traffic Signals May Open New Avenues For The Treatment Of Schizophrenia
- My Experience with Schizophrenia/Schizoaffective Disorder
- More Evidence Confirms Relevance of Risk Allele to Schizophrenia
- Metformin Resolves Amenorrhea in Antipsychotic-Treated Schizophrenia
- Intranasal Oxytocin May Ease Schizophrenia Symptoms
- Depot Injection Boosts Antipsychotic Compliance in Schizophrenia
- Computer Training Leads to Lasting Improvements in Schizophrenia
- Are Schizophrenia Simulations Accurate?
- An Introduction To The Substantia Nigra In Schizophrenia
- An Introduction To The Putamen In Schizophrenia
- An Introduction To The Nucleus Accumbens In Schizophrenia
- An Introduction To The Caudate In Schizophrenia
- ‘Mind-Pops’ More Common in Schizophrenia
Sleep Disorders
- Zolpidem Linked To Higher Inpatient Fall Rates
- What’s the connection between sleep and Alzheimer’s disease? | Sleeping with Science
- Treating Childhood Sleep Apnea Improved Cognitive Function
- Sleep-Disordered Breathing in Early Childhood Linked With Behavioral Outcomes
- Sleep Problems May Increase Risk for Dementia
- Sleep and Epilepsy (Wellness Institute Whiteboard Video Series)
- Skimping on Sleep May Increase Stroke Risk
- Persistent Daytime Sleepiness Common Despite Effective CPAP
- Obstructive sleep apnea, oxidative stress and endotelial dysfunction
- Melatonin May Normalize Night Owl Sleep Schedules
- Insomnia, Hypersomnia Disorders Criteria Proposed for DSM-5
- Insomnia Drug Helps Patients Sleep Sooner, Longer
- Hot Topics in Obstructive Sleep Apnea – A European View
- Home Sleep Apnea Testing: Wake Up Call for Sleep Docs
- FDA Approves Low-Dose Zolpidem for Night Awakening
- ESRS Sleep Medicine Textbook
- ESRS Celebrates certification of more than 1100 Somnologists and Somnologist Technologists
- Depression and Sleep
- CPAP Improves Mood in Sleep Apnea Patients
- Cancer More Common in People With Sleep Apnea
- ‘On-Off’ Switches Shed Light on Brain Disorders : Narcolepsy, cataplexy, and REM sleep behavior disorder linked to errant ‘flip-flop’ mechanisms.
Slider Content
- Wfnr Franz Gerstenbrand Award
- The Increased Production Of Hydrogen Sulfide In Amyotrophic Lateral Sclerosis Is A Significant Risk Factor?
- The FENS Forum
- Panel Discusses Direction Of Alzheimer’s Disease Research
- Occipital Nerve Block For Cluster Headache: Two Thumbs Up
- Niemann-Pick Type C Disease (NP-C)
- Miniature Neurostimulator Zaps Chronic Cluster Headache
- Idiopathic Environmental Intolerance: A Comprehen-Sive And Up-To-Date Review Of The Literature
- Hallucinations And Mental Health In Children
- Doctors May Commonly Misdiagnose Creutzfeldt-Jakob Disease
- Depression Can Be Migraine’s Tipping Point
- Critical European Brain Bank Being Dismantled
- Cognitive Impairment Seen in Childhood CNS Vasculitis
- Citicoline Failed To Improve Function Or Cognition In TBI Patients
- Chronic Musculoskeletal Pain Travels With Chronic Daily Headache
- Botox May Greatly Reduce Migraine Chronicity
- Apo E-Epsilon 4 Confers Attentional Benefits In Early Adulthood
- 2016 Wfnr Franz Gerdtenbrand Award Open For Entries
Stroke
- What is the future for NOACs in secondary prevention of ESUS? – Christina Sjöstrand, Hans-Christoph Diener & George Ntaios
- Transforming the stroke care continuum together
- Three Part Round Table Discussion: Which Techniques To Achieve FPE? Experts Share Their Daily Practice
- Protected: The Novel Oral Anticoagulants For Af…What Do The Sub-Analyses Tell Us?
- The Impact Of Thrombectomy For Stroke Patients In the UK – World Stroke Day 29th October 2022
- The impact of COVID-19 on Hemorrhagic Procedures
- The changing world of innovative stroke treatment
- The Angels Initiative: Stroke care taking flight with the wings of Angels – ESO-WSO Virtual Congress 2020
- The Angels Initiative at ESOC 2021
- The Angels (Acute-Networks StrivinG For ExceLlence In Stroke) Initiative: Solving A Problem By Giving Physicians The Tools They Need To Create A Solution
- Tenecteplase Edges TPA in Acute Stroke
- Strokes Mix Up Brain And Muscle Coordination
- Stroke Treatment From Onset To Rehabilitation
- Stroke Severity Is Key in Hospital Rankings for Stroke Outcomes
- Stroke Prevention in AF: Study Finds Some Differences Among New OACs
- Stroke care taking flight with the wings of ANGELS
- Stroke Association Reviewing Stroke Definition, New Anticoagulants
- Some Recommendations To Address The Burden Of Stroke In Europe
- Solitaire Trumped Merci in Stroke Clot Retrieval Trial
- Solitaire Clot Remover Effective for Large Artery Stroke
- Significant Risk Factors In The Etiology Of Arterial Ischemic Stroke In Children
- Secondary Stroke Prevention: Who Can Benefit from Device Therapies?
- Scores Help Identify Stroke Patients at Risk of Brain Bleed
- Roundtable Discussion – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention
- Role of Patent Foramen Ovale Varies in Cryptogenic Strokes
- Robots May Extend Post-Stroke Race
- REDEFINING FLOW DIVERSION WITH PIPELINE™ FLEX WITH SHIELD™ TECHNOLOGY: RELEASE OF NEW CLINICAL DATA
- RE-SPECT ESUS: Optimizing Prevention of Embolic Stroke of Undetermined Source – Mike Sharma, Richard A. Bernstein & Hans-Christoph Diener
- RE-SPECT ESUS: Dabigatran versus acetylsalicylic acid for stroke prevention in patients with embolic stroke of undetermined source – Hans-Christoph Diener
- Prof. Dr. István Szikora – Press conference in October on the national stroke imaging network
- Pretreatment ASPECTS Reading Affects Stroke Outcomes
- Pilot Program Shows Cardiac Rehab Can Help Poststroke
- Past And Future Of Stroke Care In Europe – How Can Sits Support?
- Past & Future Of Stroke Care In Europe
- Oral Relaxin Improves Poststroke Recovery
- Novel Stroke Prophylaxis Strategies: When Should Device-Based Cardiac Occlusion Therapies Be Considered?
- NOACs in Secondary Stroke Prevention – Robin Lemmens, Ales Tomek & Milan R. Voško
- New Stroke Outcome Data – Prolonged Cardiac Monitoring Prevents Secondary Strokes – Valeria Caso, Helmut Pürerfellner & Georgios Tsivgoulis
- Minimizing The Risk Of Hemorrhagic Stroke During Oral Anticoagulant Therapy For Atrial Fibrillation: The Neurologist’s Perspective
- Minimizing The Risk Of Haemorrhagic Stroke During Oral Anticoagulant Therapy For Atrial Fibrillation: The Neurologists’ Perspectives
- Meta-Analysis: Statins Don’t Prevent Stroke, Death in Women
- Mental Training For Reinstallation Of Motor Programs After Stroke – Fiction Or Science?
- Memory Declines Years Before Stroke Strikes
- Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (German)
- Medtronic – ESMINT 2021: Speaker: Professor René Chapot – Double Stent Retrievers (English)
- Mechanical Thrombectomy, The Change Is Coming.
- Mechanical Embolectomy Device Cleared for Acute Stroke Treatment
- Measurement And Improvement Of Stroke Care, Eso-East
- Maternal Hypertension Ups Infant’s Stroke Risk
- Life after stroke – what is the problem?
- Leaving A Legacy Of Stroke In Europe: A Community Of Dedicated Professionals Is Changing The Face Of Stroke In Europe
- Learnings from the ESUS trials – Jesse Dawson, Martin Grond & Maurizio Paciaroni
- Interview With WSO President: Prof. Michael Brainin
- Innovations Driven By Clinical Evidence
- Infection Correlated With Stroke Risk in Children
- In-Hospital Management Of Acute Ischaemic Stroke: How Can We Do Better?
- Implementation of Best Practice in Europe: The Angels Initiative – The Role Of ESO
- Hormonal Contraception Raises Thrombotic Stroke, MI Risk
- High-Tech Stroke Recovery Aids? More Likely Than You May Think
- Protected: From Studies To Real-Life Evidence…Latest Insights From The Garfield Af Registry
- Framingham Score Flags MI Risk After Stroke
- Filgrastim Fails to Improve Ischemic Stroke Outcomes
- Exclusive Interview With ESO President: Prof. Martin Dichgans
- Establishing stroke systems of care from the bottom to the top: A global perspective
- ESOC 2021: Shaping the future
- ESOC 2019 – MEDTRONIC CARE CONTINUUM: Improving Patient Pathway
- ESOC 2017 Conference News
- ESOC 2017 – Day 2 Highlights
- ESOC 2017 – Day 1 Highlights
- ESO Endorsed Medtronic Webinar: Cryptogenic Stroke Patients Need Answers: AF Screening Strategies & Patient Stratification
- ESO & S.A.F.E – Declaration for Action on Stroke launches on European Stroke Awareness Day
- ESO / SAFE Press Release: Ukraine signs the Stroke Action Plan for Europe Declaration
- ESC 2014. In-Hospital Management Of Acute Ischaemic Stroke: How Can We Do Better?
- Epilepsy Incidence High Following Pediatric Stroke
- Embolic Stroke of Undetermined Source (ESUS) – Valeria Caso, Danilo Toni & Martin Grond
- Elderly Stroke Patients Have High Atrial Fibrillation Prevalence
- Depressed Stroke Survivors At Increased Risk Of Death
- CT Perfusion in Acute Stroke Questioned
- Cryptogenic Stroke Webinar – ESO-WSO Virtual Congress 2020
- Clot-Busters Safely Treated Wake-Up Stroke Patients
- Boehringer Ingelheim: WSC 2018 – secondary stroke prevention: new evidence that demands a verdict
- Boehringer Ingelheim: ESOC 2019 – How NOAC selection and reversal can help protect our patients: Your questions answered
- Boehringer Ingelheim: Angels WSC 2018 – Improving Stroke Care Across The World: The Angels Initiative
- Boehringer Ingelheim: Angels ESOC 2019 – THE ANGELS INITIATIVE: 3 YEARS AND COUNTING
- Boehringer Ingelheim: Actilyse WSC 2018 – New Frontiers in Acute Ischaemic Stroke Reperfusion
- Boehringer Ingelheim ESOC 2018 – Stroke Prevention and Treatment: New Insights Into NOACS and Reversal
- Bayer: ESOC 2019 – Brain, Heart and Kidneys: Preserving the Balance in Stroke Prevention
- Atrial Fibrailation In Young Stroke Patients
- Anticoagulation for Cerebral Venous Thrombosis
- Protected: Anti-Coagulation With Novel Oac’s In Af, Practical Guidance And Interactive Session
- Angels: FAST Heroes: Results of cross-country implementation of a global school-based stroke education campaign – ESOC 2022 Studios
- Angels ESOC 2018 – Experience From Today For The Stroke Care Of The Future
- Anemia Triples Post-Stroke Mortality Risk
- An alternative treatment to prevent stroke in patients with Atrial Fibrillation: Left Atrial Appendage Occlusion-Latest evidence
- Alive or Dead? Secondary Stroke Prevention with NOACs in ESUS – Ken Butcher
- Air Pollution May Hurt Cognition, Increase Strokes
- Advanced Imaging To Extend The Therapeutic Time Window Of Acute Ischemic Stroke
- A testimonial from the ESO past president – Valeria Caso
- A message from the ESO President – Professor Valeria Caso
- ‘Drip and Ship’ Proves Safe for Stroke
Uncategorized
- Vol. 6, Jan 2021 eJournal: Coming soon…..
- Transition of ADHD Patients from Childhood into Adulthood
- Transforming Stroke Care Through Advancements in Technology and an Overview of the PROSPR-SEA Post-Market Surveillance Study
- Three years of Angels: delivering a vision of consistent improvements in stroke care, internationally
- The Unrecognised Adult ADHD Patient: accidents, brain injury and behaviour
- The Stroke Care Continuum and Patient Pathway
- The impact of COVID-19 for families with Parkinson’s Disease
- The ANGELS Initiative: More and better Stroke-ready hospitals across the globe
- The ANGELS Initiative: Improving Stroke Care in Asia
- Symposium: Redefining Flow Diversion using Pipeline™ Flex with Shield Technology™ — Release of New Clinical Data
- Stroke prevention in atrial fibrillation: update with NOAC treatment and the impact of reversal
- Stroke Prevention and Treatment: New Insights into NOACs and Reversal
- Stroke experts produced a Stroke Action Plan for Europe (2018-2030)
- Stroke care taking flight with the wings of ANGELS
- Stroke
- Stroke
- State of the art on acute ischemic stroke: Systems of Care and In-hospital Organization
- State of the art on acute ischemic stroke: late breaking clinical trials
- Serum Epidermal Growth Factor Predicts Cognitive Functions In Early, Drug-Naive Parkinson’s Disease Patients
- Selecting patients for endovascular therapy and recent developments and clinical experience with Medtronic devices
- SAFE launches a website for stroke prevention
- SAFE Angels Project: Exciting new initiative gives stroke patients expert information
- Role, Function and Effect of Catechol-O-Methyl Transferase In Humans And Parkinson Disease
- Preserving the Balance in Stroke Prevention: Brain, Heart and Kidneys (symposium summary sponsored by Bayer)
- Patients and carers expertise important for the credibility of the European Stroke Action Plan
- Overall Self-Perceived Health In Restless Legs Treated With Intrathecal Morphine
- Oruen PD Patient Role Play
- Olfaction in migraine and its psychiatric comorbidities: a narrative review
- Moving Forward With Prisms: Sensory-Motor Adaptation Improves Gait Initiation In Parkinson’s Disease
- Modified Pediatrics ASPECTS Correlates With Infarct Volume In Childhood Arterial Ischemic Stroke
- Migraine | Migraine Relief Treatment
- Medtronic Symposium, ESOC 2017 – Leopold Saltuari
- Medtronic Symposium, ESOC 2017 – Krassen Nedeltchev
- Medtronic Symposium, ESOC 2017 – Jan Gralla
- Medtronic Symposium, ESOC 2017 – Antonio Davalos
- Medtronic Meet The Experts Session – Sergio Zimatore ESOC 2017
- Medtronic Meet The Experts Session – Raffaele Augelli ESOC 2017
- Medtronic Meet The Experts – Carlos A. Molina ESOC 2017
- Looking for the ‘I’, ‘Me’ and ‘Other’ in Patient Stories
- Insights from ESOC: Improving Patient Pathways in Stroke
- Innovations in Endovascular Treatment of Acute Ischemic Stroke and Cerebral Aneurysms
- Individualized therapeutic levels: Adequate use of antiepileptic drug monitoring
- Improving stroke care across the world: the Angels Initiative
- Ideas and Innovations in Acute Ischaemic Stroke Treatment
- How NOAC Selection and Reversal Can Help Protect Our Patients: Your Questions Answered
- Functional somatic symptoms and syndromes in children and young people – a psychiatric perspective
- Full costs of stroke in 32 European countries is €60 billion
- Experience from Today for the Stroke Care of the Future
- European WAKE-UP trial shows benefit of thrombolysis in stroke with unknown time of onset
- ESMINT partners in EU funded research project: Clinical study starts in eight European countries
- Episode 4 Out Now – Reflections on Parkinson’s Disease Podcast by Professor Bas Bloem and Professor Werner Poewe
- Epilepsy research: MRI | NHS
- Epilepsy Drug Can Reverse Memory Loss In Alzheimer’s Patients
- Empowering stroke advocates through e-learning: SSOFT
- Embolic Stroke of Undetermined Source (ESUS)
- Dissection method affects electrophysiological properties of hippocampal slices
- Deep Brain Stimulation – Effects On Swallowing Function In Parkinson’s Disease
- Cognitive Rehabilitation In Parkinson’s Disease: Evidence From Neuroimaging
- Clinical Outcomes and Work Flow Optimisation with Pipeline System and Shield Technology
- Boehringer Ingelheim: Angels ESOC 2019 – THE ANGELS INITIATIVE: 3 YEARS AND COUNTING
- An introduction to the Internal Capsule in schizophrenia
- An introduction to the Globus Pallidus in schizophrenia
- An alternative treatment to prevent stroke in patients with Atrial Fibrillation: Left Atrial Appendage Occlusion – Latest evidence and discussion (2 part webinar)
- Always a good time to learn about stroke prevention
- Acute Nicotine Treatment Attenuates Learning and Memory Impairment in REM Sleep Deprivation through Modulation of CREB and BDNF Protein Expression in Rat’s Hippocampus
- A successful collaboration between SAFE and the ANGELS Initiative helps improving patient – doctor communication
